Factors enhancing adherence of toxigenic bacteria to epithelial cells in relation to Sudden infant death syndrome by Saadi, Abdulrahman Towfeeq
Factors enhancing adherence of toxigenic
bacteria to epithelial cells in relation to











I dedicate this work to my father Towfeeq, my mother Halima, my wife Awaz
and the memory ofmy uncle Najeeb
iii
Acknowledgements
With great pleasure I acknowledge my gratitude to my supervisors: Dr. Caroline
Blackwell, Prof. Donald Weir and Dr. John Stewart. It was both their humane quality
and their enthusiasm towards the subject which I admired most. Throughout these
years they provided guidance, discussions and encouragement which created a good
atmosphere for the research to be accomplished.
Many thanks to Mrs. Valerie James for her help in the laboratory work. I wish to thank
Miss Doris Mackenzie for helping with literature searches and Mr. Michael Kerr for his
technical assistance. Thanks are also due to Mr. Bill Neill for his technical assistance in
flow cytometry whenever the machine required a rescuer.
I am grateful also to Dr. Ian Poxton for his advice and discussions regarding gel
electrophoresis techniques. Thanks to Prof. D.L. Gardner and Mr. D.S. Cunningham
for their help in Confocal Scanning Optical Microscopy. Thanks also to Dr. Rob Elton
for his assistance with statistical analysis of the results.
I would like to thank all of my colleagues and the staff in the Department of Medical
Microbiology who donated samples for this research.
My thanks to Dr. Mohammed Raza for providing RSV-infected HEp-2 cells and to Dr.
Aziz Zorgani for his assistance in drawing some of the figures.




EEC Buccal epithelial cells
BI Binding index
BSA Bovine serum albumin
CSOM Confocal scanning optical microscopy
EDTA Ethylenediamine tetra acetic acid
ELISA Enzyme linked immunosorbent assay














RSV Respiratory syncytial virus
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
SIDS Sudden infant death syndrome
TNF Tumour necrosis factor
TSS Toxin shock syndrome
TSST-1 Toxin shock syndrome toxin-1
v
Abstract
Sudden infant death syndrome (SIDS) is the most common cause of postperinatal
mortality in the developed world. The most consistent epidemiological finding is that
the peak incidence of these deaths occurs between 2-4 months. This study tests the
hypothesis that the Lewisa antigen expressed by 80-90 % of infants in the 2-4 month
age range is one of the host receptors for two toxigenic bacteria species suggested to
be involved in cot death, Staphylococcus aureus and Bordetella pertussis. Although
respiratory viruses are often isolated from SIDS infants, there is no direct evidence for
their involvement in these deaths; however, this study examined the effect of virus
infection on binding of S. aureus and B. pertussis to epithelial cells in culture.
By flow cytometry, binding of three toxigenic strains of S. aureus to cells from non-
secretors was significantly greater than to cells of secretors. Pretreatment of epithelial
cells with monoclonal anti-Lewisa, anti-type 1 precursor or anti-Lewisx significantly
reduced bacterial binding; but binding of S. aureus was significantly correlated only
with the amount of Lewisa present on the epithelial cells. Binding of B. pertussis to
epithelial cells was also significantly inhibited by pre-treatment of the cells with anti-
Lewis3 or anti-Lewisx. A 67 kDa protein was isolated from cell membrane
preparations of S. aureus (NCTC 10655) by affinity adsorption with synthetic Lewis3
antigen conjugated to Synsorb beads. Pre-treatment of BEC with the purified protein
reduced binding of staphylococcal strains to a greater extent than with the material not
bound to the Synsorb beads.
Respiratory Syncytial Virus (RSV) infects about 50% of infants by the first year of life
and it is often isolated from infants with SIDS. RSV-infected HEp-2 cells bound
significantly more S. aureus or B. pertussis than uninfected cells.
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The findings of this study help to explain some of the epidemiological factors
associated with SIDS, the age range affected and the winter peak of these deaths. The
significance of these findings is discussed in the context of recent recommendations for
infant care procedures, changes in infant immunization schedules and the steady
decline in SIDS observed since 1990.
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In spite of the improvement in living conditions and general health of the population
world-wide, a significant proportion of infants die suddenly without apparent cause of
death. Many epidemiological and pathological studies indicate infectious agents might
be involved in the aetiology of these infant deaths.
The aim of this chapter is to review the current concepts of the epidemiology and
aetiology of sudden infant death syndrome (SIDS), in particular the toxigenic bacteria
which have been implicated in SIDS, in the context of genetic, developmental and
environmental factors associated with susceptibility to infectious agents.
1.1 SIDS
The term "cot death" was first used by Barret [1954] to describe the unexpected death
of a healthy baby during sleep. Some used the synonym "crib death". Cot death
includes sudden unexpected infant death. The causes of some might be explained, some
partially explained and others unexplained. Those for which the causes are totally
unexplained or partially explained are classified as sudden infant death syndrome.
The term SIDS is a pathological diagnosis of exclusion. The most accepted definition
was proposed by Beckwith [1970]: "The sudden death of an infant or young child
which is unexpected by history, and in whom a thorough autopsy examination fails to
demonstrate an adequate cause of death". The recent revised definition for SIDS is:
"The sudden death of an infant under one year of age which remains unexplained after
a thorough case investigation, including performance of a complete autopsy,
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examination of the death scene, and review of the clinical history [Willinger et al.,
1991]". Bartholomew et al. [1987] found a definite cause of death in about 8% of cot
deaths and possible contributory factors in a further 22%. They emphasised that there
is no clear epidemiological distinction between true SIDS and those deaths which were
explainable.
1.2 Epidemiology of SIDS
SIDS is the major cause of death in infancy between the first week of life and one year.
It has a characteristic age distribution with a clear peak around the third and the fourth
months of life, and about 80% of the cases occur during the first six months of age
[Frogatt et al., 1971],
Despite a steady decline in infant mortality in the UK over the last decades from 14.4
per 1000 live births in 1975 to 8.3 in 1989, the incidence of SIDS remained at about 2
per 1000 live births [Finlay and Rudd, 1993], There was a drop in the annual death rate
of SIDS during the last few years. These figures are similar to those reported for
Australia and the United States. The highest incidence of SIDS has been reported from
New Zealand and the lowest from Hong Kong (Table 1.1). There are more males
among the sudden unexplained deaths than among others in the same age range who
died of other causes [Jorgensen et al., 1979; Gibson, 1992],
1.2.1 Weather and season in relation to SIDS
There is a winter peak of SIDS cases in the UK [Carpenter and Gardner, 1990] and
South Australia [Beal, 1983], but this pattern is not found in Scandinavia [Beal and
Porter, 1991]. Standfast et al. [1979] found the overall seasonal pattern of SIDS in
New York resembled that of viral respiratory infections.
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Table 1.1 The incidence of SIDS
Country No/1000 live births Reference
England and Wales 1.7 [Wigfield et al., 1992]




















[SIDS by states and territories, 1988]
[SIDS by states and territories, 1988]
[Borman et al., 1988]
[Borman et al., 1988]
[Irwin et al., 1992]
[Irwin et al., 1992]
[Blok, 1978]
Hong Kong 0.3 [Lee et al., 1989]
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1.2.2 Maternal factors
Mothers' smoking has been identified as a risk factor for SIDS [Gibson, 1992; Scragg
et al., 1993], Children of mothers who smoke have more respiratory tract infections
[Bonham and Wilson, 1981]; and smokers are more likely to carry pathogenic bacteria
such as meningococci [Blackwell et al., 1990; Blackwell et al., 1992] or staphylococci
[Musher and Fainstein, 1981].
Rajegowda et a/.[1978] found the incidence rate of SIDS of narcotic-dependent
mothers was 5.5 fold higher than for all the babies born during the same time and in the
same place. The intrauterine exposure to narcotics and its subsequent effect on central
control of respiration in the young infant might be one of the underlying mechanisms
for drug-related cases of SIDS. Other maternal factors associated with SIDS are:
unmarried mother; young mother; high parity order; short inter-pregnancy interval; low
birth weight; twins and poor attendance at antenatal clinics [Golding et al., 1985],
1.2.3 Social factors
There is a relationship between poor social conditions, increased morbidity, and SIDS
[Biering-Sorensen, 1979], Two factors associated with lower socioeconomic
conditions are a higher proportion of women who smoke [Wald et al, 1988] and the
lower proportion who breast feed. Like respiratory and gastrointestinal illnesses, SIDS
is reported to be associated more frequently with bottle feeding [Arnon, 1984].
1.3 Pathological findings in SIDS
Although the diagnosis of SIDS is to some extent one of exclusion, there are a number
of typical findings which are of value in diagnosis [Berry and Keeling, 1989]. Petechiae
on the face are very rare in SIDS and raise the question of accidental suffocation.
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Frothy fluid escaping from the nose and mouth is seen in more than half of SIDS
victims and evidence of sweat in clothing suggests overheating [Fleming et al., 1990],
Internal examination shows petechial haemorrhages in the thymus in a majority of
cases and prominent lymph nodes. The lungs are usually well inflated. Minor
inflammation and infection of the respiratory tract is common in SIDS. Mild fatty
change in the liver is very common and is probably a non-specific marker of metabolic
disturbances which accompany many types of illness or stress [Sinclair-Smith et al.,
1976; Bonnell and Beckwith, 1986]. The abnormal persistence of fetal haemoglobin
and raised hypoxanthine levels in the vitreous humor might be due to periods of
premortem hypoxia [Giulian et al., 1987], There is often gliosis in the brain stem
[Becker, 1983] which might be the result of hypoxia or low grade inflammation. There
is a delay in myelination and maturation of dendritic spines [Kinney et al., 1991],
possibly due to the effect of passive exposure to cigarette smoke.
1.4 Theories proposed for the aetiology of SIDS
Epidemiological studies have led to several hypotheses; however, none can adequately
explain all cases or all the features identified in the surveys.
1.4.1 Sleeping position
There is a fear that babies sleeping supine are at increased risk of aspiration of vomitus,
although this has not been established. Studies which looked at sleeping position found
that the prone position was more common in babies dying of SIDS than in control
babies [Beal and Finch, 1991]. The low incidence of SIDS in Hong Kong, which has a
hot, humid climate and where infants sleep supine, has led to the suggestion that the
prone position could be a risk factor [Lee et al., 1989], Studies in the Netherlands
[Engelbert and de Jonge, 1990], New Zealand [Cowan, 1991] and in Avon [Wigfield
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et al., 1992] have shown a decline in the number of the infants dying from SIDS, and
this decrease has been attributed to the campaign to discourage the prone sleeping
position. These findings need more extensive examination of non-SIDS post-neonatal
infant mortality rates in order to show that the decline in SIDS rate is not related to
other factors. The SIDS rate in Scotland has fallen from 2.2 per 1000 in 1989 to 1.3
per 1000 in 1991 [Gibson et al., 1991], but there were no changes in infant care
specifically recommended in this population.
1.4.2 Clothing and overheating
Room temperature, excess clothing and bedding are among the factors that could
result in overheating of an infant. Overinsulation has been suggested to be a risk factor
for SIDS. Fleming et al. [1990] showed that babies over 70 days of age who were
wrapped in clothing and bedding in excess of 10 togs were 12 times more likely to die
than babies wrapped in clothing and bedding less than 6 togs. The prone sleeping
position will reduce heat loss by reducing the body surface area available for heat loss.
In a heavily wrapped baby, the head, particularly the face, becomes the main route for
heat loss, up to 85% of heat loss in the infant in bed [Wailoo, 1989]. When thick
clothing and bedding are used, the thermoregulatory mechanisms could be
compromised by the prone sleeping position [Nelson et al., 1989],
The infant is vulnerable to changes in brain temperature. In animal studies small
changes in hypothalamic temperature have profound effects on the control of
respiration [Parmggiani, 1987]. Infection increases the infant's basic metabolic rate and
increases heat generation which could result in a significant change in thermal balance.
In the Avon studies overwrapping in the presence of a viral infection increased the risk
of SIDS [Gilbert et al., 1992], There is evidence that heat stress may be associated
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with SIDS [Stanton, 1984; Sunderland and Emery, 1981] or with marked
hypoventilation [Gozal et al., 1988].
1.4.3 Apnoea and respiratory failure
It has been suggested that healthy babies with viral infections often suffer from central
apnoea, and babies with nasopharyngitis were more likely to become apnoeic
[Steinschneider, 1975]. Prolonged apnoea and airway obstruction could be part of the
pathophysiological process causing SIDS. Steinschneider et al. [1982] suggested that
unstable respiratory activity during sleep as well as pharyngeal / laryngeal dysfunction
might be induced by liquid stimulation. Southhall et al. [1990] recorded severe arterial
hypoxaemia and intrapulmonary shunting in young children with recurrent cyanotic
episodes. The most common stimulus was pain, fear or anger, and the onset of severe
cyanosis was rapid with rapid loss of consciousness. Narrowing of the upper airways
could be caused by respiratory infection and also lead to obstructive or possibly central
apnoea [Tonkin et al., 1979; Guilleminault, 1987; Guntheroth, 1989].
A study on the ventilatory response to hypoxia and hypercapnia in subsequent siblings
of SIDS victims found that after 5 weeks of age, siblings of SIDS had a normal
response to hypercapnia; however they responded to mild hypoxia with periodic
breathing. Arousal occurred during 25% of the hypoxic challenges in the controls but
was not seen in the siblings of SIDS victims [Brady and McCann, 1985]. This
instability in ventilation might lead to severe apnoea and sudden death in the presence
of other factors.
1.4.4 Cardiovascular abnormalities
Congenital malformation of the conduction system of the heart might lead to sudden
death from asystole or ventricular fibrillation [Southall, 1983]. Babies with this
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malformation have prolonged Q-T intervals, a condition not easy to identify by morbid
anatomical techniques. Schwartz [1976] suggested the cause of some SIDS could be
sudden increases in sympathetic activity leading to imbalanced cardiac innervation. On
the other hand, Steinschneider [1978] showed that the Q-T intervals in the siblings of
victims did not differ from those of control infants, nor did the Q-T interval of parents.
Kelly et al. [1977] concluded that prolonged Q-T interval does not play a major role in
the genesis of either near-miss episodes or sudden infant deaths. Both heart rate and
respiratory rate were greater in the preterm babies than in the term infants throughout
the first six months of life; and, according to this concept, sudden infant death is linked
to a vulnerable phase of cardiorespiratory maturation [Katona et al., 1978]. Recently a
study by Meny et al. [ 1994] has shown that bradycardia was an important feature in
SIDS.
1.4.5 Metabolic disorders
A small percentage of babies who die from SIDS have an inborn error of metabolism
[Emery et al., 1988]. An abnormality of fatty acid [3-oxidation, medium chain acyl
coenzyme-A dehydrogenase (MCAD) deficiency, could be responsible for 3% of cases
of SIDS [Howat et al., 1984]. This possibility needs to be considered in cases showing
micro-vesicular fatty changes in the liver and other organs [Howat et al., 1986]. The
enzyme is important in the metabolism of fatty acids in the liver and plays an essential
part in maintaining energy homeostasis during fasting. Asymptomatic presentations
were reported in 12% of MCAD deficiency victims [Touma and Charpentier, 1992];
otherwise, in MCAD, the sufferers present characteristically with vomiting, lethargy
and hypoglycaemia that is provoked by fasting [Roe and Coates, 1989]. In a recent
study by Miller et al. [1992] MCAD deficiency did not make a significant contribution
to the aetiology of SIDS. A study by Burchell et al. [1989] has linked the deficiency in
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glucose-6 phosphatase enzyme which is an inborn error of metabolism with few cases
of SIDS.
1.4.6 Immunological abnormalities in SIDS
Lymphoid tissue in the lungs and spleen of SIDS victims can be more prominent than
in controls suggesting prior episodes of infection [Emery and Dinsdale, 1974; Barzanji
et al., 1976]. Many studies have failed to demonstrate a consistent abnormality in
humoral immunity [Valdes-Dapena, 1982], Recently Stoltenberg et al. [1992] reported
evidence that the mucosal immune system is stimulated in SIDS. They found higher
numbers of IgM immunocytes in the tracheal wall and significantly higher IgA cells in
the duodenal mucosa of SIDS victims compared with a group of infants that died from
non-infectious causes.
Anaphylaxis to cows' milk has been suggested as a cause of some cases of SIDS
[Coombs and McLaughlan, 1982] but there was neither a consistent association of
SIDS with atopy [Warnasuriya et al., 1980] nor an association of an increase in total
serum IgE with milk or in allergen-specific IgE [Mirchandani et al., 1984; Clark et al.,
1979]. An increase in specific IgE against a fungus Aspergillus fumigatus and a house
dust mite Dermatophagoides pteronyssinus has been reported [Turner et al., 1975],
Howat et al. [1994] found that the victims of SIDS have three times more eosinophils
in their lungs, accompanied by increased T lymphocytes and B lymphocytes and there
were more peribronchial mast cells compared to those for controls. Eosinophils can
produce the potent pyrogenic cytokines TNF-a and macrophage inflammatory protein-
la [Costa et al., 1993] which could cause life-threatening hyperpyrexia. In addition,
they can secrete both oxygen free radicals and cytotoxic proteins [Frigas and Gleich,
1986] which could lead to pulmonary oedema.
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Mast cells are important factors in immediate hypersensitivity reaction [Holgate and
Church, 1992], There are some indications for mast cell degranulation in SIDS
[Harrison et al., 1993; Walls et al., 1993], The latter team found an increase in serum
tryptase which is a marker for the degranulation.
1.4.7 Infectious agents
Infants are particularly vulnerable to infection during the period when most cases of
SIDS occur (2-4 months). This is when maternal antibodies have declined and the
infant immune system is immature.
1.4.7.1 Association of viruses with SIDS
The findings that many SIDS infants experienced minor respiratory illness before death
suggested these deaths might be caused by viruses. In areas with a temperate climate,
cot deaths occur most often in the winter months during which epidemics of
respiratory virus infection are common. Epidemiological studies provided inconsistent
evidence that respiratory viruses are involved in SIDS, and different research workers
have drawn different conclusions concerning the significance of viruses in the aetiology
of SIDS. Gilbert et al. [1992] pointed out that viral infection alone was not a major
risk factor as long as babies were lightly wrapped; but, in the heavily wrapped babies,
the presence of a viral infection greatly increased the risk of death.
The technical problems associated with identification of viruses probably resulted in
the underestimation of their presence among SIDS cases in early studies [Fleming,
1992], A recent study in which the polymerase chain reaction (PCR) technique was
used to detect viral nucleic acids in tissues from SIDS infants and infants who died of
known causes, found a higher proportion of SIDS infants had evidence of virus
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infection, mainly adenoviruses [An et al., 1993]. Other viruses identified among SIDS
infants include: influenza vims [Nelson et al., 1975; Zink et al., 1987]; enterovirus
[Danes, 1989]; rhinovirus [Las Heras et al., 1983]; and rotavirus [Yolken and Murphy,
1982],
In two out of three studies, there was an association between the peak of SIDS and
total viral respiratory isolates in the community [Carpenter and Gardner, 1990; Uren et
al., 1980]. A survey of SIDS cases and controls matched for age, time and
geographical area found no differences in isolation of viruses [Gilbert et al., 1992],
Only a weak association of viruses with SIDS has been reported in a New Zealand
survey [Ford et al., 1990].
One of the viruses commonly associated with SIDS is respiratory syncytial virus (RSV)
[Ogra et al., 1975; Williams et al., 1984], In a major Australian study, 90% of RSV
isolates were from SIDS infants older than 3 months [Williams et al., 1984], It has
been suggested that viral infection might be more important in those SIDS cases aged
over 3 months in which evidence of respiratory tract inflammation has been found at
autopsy [Williams, 1980],
1.4.7.2 Association of toxigenic bacteria with SIDS
There has been no substantial evidence for invasive bacterial infections in SIDS
[Banks, 1958 and Valdes-Dapena, 1967]; therefore much of the work on the role of
bacteria in SIDS has concentrated on species that produce exotoxins (Table 1.2).
A characteristic feature of SIDS is the age distribution. In a hypothesis paper by
Morris et al. [1987] the age distribution of SIDS which rises from birth to a peak at 4
months and is followed by a progressive fall matched the predicted age distribution
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Table 1.2 Toxin producing bacteria implicated in SIDS.
Species Toxin
Staphylococcus aureus A, B, C, D and TSST-1.
Bordetella pertussis pertussis toxin
Escherichia coli enterotoxin
Clostridium botulinum A, B, C, F and G
Clostridium difficile A and B
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curves for susceptibility to bacterial toxins. At the time maternal antibodies are
declining, infants will be vulnerable to bacterial toxins produced by the normal
microbial flora.
Brandt [1970] found significant bacterial isolates in the lung tissue or blood of 16% of
SIDS victims and Telford et al. [1989] isolated S. aureus, Streptococcus viridans and
Escherichia coli more commonly from 46 SIDS victims than from healthy live babies.
A significantly higher proportion of toxigenic bacteria and their toxins were found in
faecal samples of SIDS babies than samples from the comparison group, these toxins
were also found in serum from the SIDS babies [Murrell et al., 1993].
1.4.7.2.1 Toxigenic bacteria in the intestinal tract
Infant botulism can account for some unexpected infant deaths. C. hotulinum toxin
was found in the intestines of 4% of cot deaths in the United States [Arnon et al.,
1987] and up to 16% of those investigated in Sweden [Sonnabend et al., 1985]. There
is little evidence for this in the United Kingdom [Turner et al., 1978],
In an experimental model, toxins A and B from C. difficile produced a rapid death in
the infant rhesus monkey [Arnon et al., 1984], but there is little evidence to suggest
that C. difficile is more common among SIDS infants [Gurwith et al., 1981;
Cooperstock et al., 1982], C. perfringens enterotoxin A has been identified in
gastrointestinal contents and sera of some SIDS infants, but it is not clear if the toxin is
responsible for these deaths [Murrell et al., 1987], Toxigenic E. coli were also isolated
in a greater number of SIDS victims compared to normal control infants [Bettleheim et
al., 1989; Bettleheim et al., 1990],
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1.4.7.2.2 Toxigenic bacteria in the respiratory tract
Two toxigenic bacteria that colonize the respiratory tract have been suggested to be
involved in SIDS, Bordetella pertussis [Nichol and Gardner, 1988] and S. aureus
[Morris et al., 1987],
B. pertussis and SIDS
Although there are no reports that B. pertussis has been isolated from SIDS infants,
they are difficult to culture even from children with symptomatic whooping cough
[Davis et al., 1990]. A study by Thomas and Lombart [1987] reported that the rate of
isolation of B. pertussis was 35% among individuals with typical disease manifestations
of pertussis while the rate was only 4% among those with asymptomatic disease.
Young infants with pertussis do not whoop, but can have expiratory apnoea and there
is an excess of unexplained infant deaths during epidemics of whooping cough [Nicoll
and Gardner, 1988]. There is a suggestion that among infants not immunised against
diphtheria, pertussis and tetanus (DPT) there is increased risk of infection which could
lead to hypoxaemia [Southall et al., 1988].
B. pertussis produces several toxins which contribute to the pathophysiology of the
striking effects caused by these bacteria. Among these toxins are pertussis toxins and
filamentous haemagglutinin. Both of these toxins are expressed on the surface of B.
pertussis [Tuomanen and Weiss, 1985; Cowell et al., 1986]. The absence of either of
these components greatly diminished the ability of the bacteria to attach to human
ciliated respiratory cells [Tuomanen et al., 1985], Pertussis toxin is also known as
lymphocytosis promoting factor, histamine-sensitising factor, or islet-activating
protein. It is an A-B toxin: B is the binding oligomer and the A is the enzymatically
active part. It has been reported that Lea and Lex are receptors for the toxin [van
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t'Wout et al., 1992], Pertussis toxin acts by ADP ribosylating the GTP-binding protein
of the mammalian membrane [Ui, 1988]. Its main activities in the mouse are: an
adjuvant for IgE antibodies; sensitisation to histamine and serotonin; enhancement of
insulin secretion; and induction of leukocytosis and lymphocytosis [Munoz, 1985], The
cause of death in some cases of SIDS could be hypoglycaemia via the toxin's effect on
the islets. Pertussis toxin enhances hypersensitivity reactions, and degranulation of
mast cells have been observed in autopsy material from SIDS infants [Harrison et al.,
1993; Howat et al., 1994],
S. aureus and SIDS
There is indirect evidence that nasopharyngeal colonization by toxigenic strains of S.
aureus, particularly those producing the toxic shock syndrome toxin-1 (TSST-1),
might be associated with some of these infant deaths [Morris et al., 1987]. Compared
with healthy live infants (28.3%), S. aureus was isolated from a higher proportion of
SIDS infants (41.3%) [Telford et al., 1989]. Among the S. aureus strains 30-50% are
toxigenic [Mackie and McCartney, 1989], Recently, a study by Murrell et al. [1993]
found 66.7% of the S. aureus isolated from faecal samples of SIDS cases were
enterotoxigenic ones compared to 85.7% non-toxigenic among the isolates from
healthy babies. One study has identified the staphylococcal enterotoxin C in the
kidneys of 36% of SIDS infants compared with 12% of non-SIDS infants [Malam et
al., 1992]. TSST-1 was detected by immunohistochemical techniques in 9 of 50
kidneys from SIDS infants compared with 3 of 50 control necropsy kidneys
[Newbould et al., 1989],
S. aureus is a versatile human pathogen capable of causing a variety of diseases,
ranging from minor skin infections to life-threatening conditions such as toxic shock
syndrome. Its versatility is mirrored in the range of virulence factors that it is capable
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of producing. Among these factors are a group of enterotoxins: A, B, Cj_3, D, E,
staphylococcal exfoliative toxin, toxic shock syndrome toxin-1 (TSST-1). The term
'superantigens' has been suggested for these proteins and other proteins that have in
common an extremely potent stimulatory activity for T lymphocytes. The process of
stimulation of T-cells leads to production of cytokines by T-cells and monocytes
[Mosmann and Coffman, 1989]. In vitro stimulation of human or murine cells with
these toxins induced interferon-y, interleukin-2 (IL-2) and tumour necrosis factor
(TNF) [De Azavedo et ai, 1988; Micusan et al., 1989]. The levels of IL-2, IL-6 and
TNF in the serum of patients with meningococcal septic shock correlated with fatal
shock [Waage et al., 1989].
The pyrogenic staphylococcal toxins and streptococcal pyrogenic exotoxins are
powerful substances which can kill previously healthy adults [Bohach et al., 1990],
They are potent inducers of fever (> 38.5°C) and might account for the high
temperatures recorded for SIDS infants at the time of autopsy [Sunderland and Emery,
1981], Both Interleukin-1 (IL-1) and TNF are thought to induce fever by the
production of prostaglandin E2 (PGE2) in the preoptic area of the hypothalamus
[Dinarello and Wolff, 1982; Dinarello et al., 1986], IL-1 has been suggested to cause
deep sleep associated with prolonged periods of apnoea [Guntheroth, 1989], pyrogenic
toxins enhance endotoxic shock and also cause enhancement of delayed type
hypersensitivity [Schilievert et al., 1979],
1.4.7.3 Synergy between toxins and environmental factors
There is no consistent evidence for either temporal or geographical clusters of SIDS
[Golding et al., 1985]. This suggests that a single infectious agent is probably not
responsible for SIDS; however, synergistic effects between infectious agents or toxins
and environmental factors might be involved in SIDS. In experimental models, synergy
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occurs between toxins of the same microorganism or between toxins of two different
microorganisms, as in the case of an enhanced lethality of staphylococcal toxin in the
presence of preparations from E. coli in the chick embryo model [Drucker et al.,
1992]. Similarly, S. aureus TSST-1 and endotoxin showed enhanced toxicity on
chicken embryos when both toxins were combined [de Azavedo et al., 1985],
Synergy between bacterial toxins (staphylococcal a and 7 toxins, endotoxins and
diphtheria toxin) and influenza virus infection have been observed in the infant ferret
model [Jakeman et al., 1991; Smith and Sweet, 1988]. In clinical medicine, toxic shock
syndrome caused by toxin producing staphylococci has been identified as a
complication of influenza or influenza-like illness [McDonald et al., 1987], and
endotoxin is found in the blood of patients with toxic shock syndrome [Stone and
Schlievert, 1987],
Mothers' smoking was identified as a factor for SIDS in the New Zealand studies
[Mitchell, 1991; Scragg et al., 1993]. Children in households where there are smokers
have more respiratory tract infections [Bonham and Wilson, 1981], Among studies of
exposure to cigarette smoke and infection, as a rule, the strongest associations are
found with smoking habits of the mother [Pershagen, 1986].
Smokers are also more likely to carry potentially pathogenic bacteria in the throat, e.g.,
meningococci [Blackwell et al., 1990; 1992] and staphylococci [Musher and Fainstein,
1981]. The prolonged intimate contact between mother and infant could result in
greater risk of exposure to potentially pathogenic bacteria resident in the mother's
nasopharynx.
Smoking and passive exposure to cigarette smoke might also increase susceptibility to
respiratory viral infection and subsequent colonization by staphylococci [Ramirez-
ronda et al., 1981],
17
1.5 Blood group antigens and susceptibility to infectious
agents
The first significant associations between blood group phenotypes and human diseases
were noted in 1953 by the discovery of an association between blood group A and
carcinoma of the stomach [Aird et al., 1953], The reports of associations between
human disease and ABO blood groups and the ABH secretor system were collected
and reviewed by Mourant et al. [1978]. Non-secretors were over-represented among
patients with rheumatic fever and also among asymptomatic carriers of group A
Streptococcus pyogenes [Haverkorn and Goslings, 1969]. Subsequent epidemiological
studies demonstrated increased susceptibility of non-secretors of ABH blood group
antigens to infections due to some bacteria and yeast [Blackwell et al., 1989].
This section is organized to provide: a brief review of blood groups and disease
susceptibility; a review of the structures, genetics and control of expression of blood
group antigens in relation to secretor status; and the hypotheses proposed to explain
the epidemiological associations between blood groups and secretor status and
susceptibility to infectious agents.
1.5.1 Summary of epidemiological studies
Epidemiological studies have found associations between infectious diseases and ABO
blood group antigens (Table 1.3). Evidence for associations between non-secretion of
ABO blood group antigens and susceptibility to bacterial and fungal infection have
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been noted. In contrast, studies of secretor status and viral infection indicate secretors
are at greater risk of infection (Table 1.4). Also an association was observed between
non-secretion and some autoimmune diseases for which infectious aetiologies have
been proposed; among patients with spondyloarthropathies [Shinebaum et al., 1987],
insulin dependent diabetes mellitus [Blackwell et al., 1987] and Graves' disease
[Collier et al., 1988],
1.5.2 ABO blood group antigens
The ABO blood group sysLem in humans was first recognised by Landsteiner in 1901.
By mixing separated sera with suspensions of red cells obtained from different
individuals, a pattern of agglutination reactions was observed; and from these
observations, four major blood groups were identified (Table 1.5).
The frequencies of the four ABO groups vary in different populations [reviewed by
Race and Sanger, 1975]. In the United Kingdom the percentage for each group is: A
(42%); B (8.5%); AB (3%); O (46.5) [Mollison et al., 1987], American Indians are
almost exclusively group O while Asians have a higher incidence of group B.
Only man and the great apes have red cells expressing ABH antigens. The A and B
blood group antigens are major histocompatibility antigens [Joysey et al., 1977;
Hershko et al., 1980] and their incompatibility is a cause of graft and transplant
rejection for many tissues and organs. The antigens of the ABO blood groups appear
to be absent from the central nervous system.
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Table 1.5 Antigens and isohaemagglutinins of the ABO blood group system
Group Antigens on red cells Antibodies in serum
A A, H* Anti-B
B B, H* Anti-A
AB A, B, H* None
O H* Anti-A and Anti-B
* H is the antigen found on group O cells; H is also present on cells of the other 3
groups.
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New-born infants do not produce isohaemagglutinins until 3-6 months of age. The
naturally occurring antibodies of the majority of group A or B individuals are mainly
IgM and produced in response to A and B-like antigens in the environment, such as
those microbes in the gut and respiratory tract. A and B-like antigens have been
detected in a variety of microorganisms and animal tissues [Springer, 1956; Springer,
1965]; and it is suggested these antigens induce isohaemagglutinins in humans.
1.5.3 Genetics of the ABO blood groups and secretor status
The genes controlling the expression of A or B antigens are autosomal dominant alleles
present on chromosome 9 [Westerveld et al., 1976]. Group O individuals possess a
recessive allele at the ABO locus on both homologous chromosomes. The O allele is
thought to code for a functionally inert protein incapable of modifying the H antigen
[Yamamoto et al., 1990] while A and B genes code for a N-acetylgalactosamine- and
galactosyl-transferase respectively.
ABH antigens can be detected in most secretions and tissues of the human body
[Clausen and Hakomori, 1989]. They can be detected in the semen and the saliva of
the majority of individuals. These individuals are called secretors while those in whom
ABO antigens are not found in body fluids are called non-secretors. The ability to
secrete the ABO blood group antigens into body fluids is controlled by the secretor
(Se) gene which is located on chromosome 19 [Watkins, 1980]. The Se gene is
inherited in a Mendelian dominant pattern; therefore, secretors are either Se/Se or Seise
and their predicted proportion within a population is 75-80%. Non-secretors are se/se
and represent about 20-25% of the population [Race and Sanger, 1975], This ratio can
vary widely in different ethnic groups and some geographically isolated populations
[Mourant et al., 1978; Eriksson et al., 1986],
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The phenotype O is thought to be due to a gene that does not produce a gene product
since no antibody was found that reacted with O cells but did not react with cells
bearing the A or B antigens. An extract of the European gorse bush Ulex europaeus
agglutinates blood cells of different types and it is suggested that this reagent identified
an antigen on the surface of the red cell that is characteristic of type O red cells. This
antigen is called the H antigen.
The antigen H is present on red cells of nearly all humans. The H and Se genes are
closely linked on the short arm of chromosome 19 [Oriol et al., 1986]. Le Pendu
[1983] found two different forms of fucosyl transferases associated with the H and Se
genes. Bombay individuals have the h/h, se/se genotype and fail to express ABH
antigens in cells or secretions [Oriol et al., 1981]; whereas individuals with the para-
Bombay phenotype have h/h, Se/Se or h/h, Se/se. They will express type 1 precursor
and products derived from it in their secretions but will have no ABH antigens on their
red cells.
1.5.4 Structure of the ABH antigens
The first insight into the structures of these antigens came from the work of Morgan
and Watkins. A, B and H substances are found as glycolipids, mainly present in the cell
membranes, and as glycoproteins, mainly present in secretions. A, B, or H antigens are
found on a variety of precursor molecules. There are 4 main types of these precursor
molecules (Table 1.6) to which different monosaccharides are added by glycosyl
transferases to produce the A, B and H antigens. Type 1 chains are found mainly in
secretions. Type 2 chains [Oriol et al., 1986] are found on the red cells as well as most
other cells of the body except the brain. Not much information is available with regard
to type 3 and 4 precursor chains [Clausen et al., 1986].
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On red cells, the H type 2 antigen is produced by the transfer of a fucose molecule
from guanosine diphosphate L-fucose to the terminal galactose molecule at the C2
position by the a-1—>2 fucosyltransferase encoded by the H gene (Figure 1.1). The A
and B antigens are formed from the H antigen [Painter et al., 1965; Lloyd et al.,
1966]. For individuals with the A gene, the glycosyltransferase adds an N-
acetylgalactosamine (GalNac) residue from uridine diphosphate N-acetylgalactosamine
in an ocl-3 bond to the H antigen. The B gene codes for an enzyme that transfers a
galactose (Gal) residue from uridine diphosphate D-galactose to the same acceptor.
For AB individuals some chains will carry the A determinant and others will have the B
determinant [Watkins, 1967]. These enzymes can glycosylate both simple, straight
chain, and complex molecules provided that the terminal residues form the H antigen.
In secretions, the type 1 chain is fucosylated by a 1-2 fucosyl transferase coded for by
the secretor gene to produce H type 1 [Watkins et al., 1988]. H type 1 acts as a
substrate for A or B glycosyltransferase to form A or B determinants (Figure 1.2)
Table 1.6 Structures of precursor chains
Gaip 1 —>3GlcNac[31—>R Precursor type-1
Galp 1 —>4GlcNacP1 —>R Precursor type-2
Gaip 1 —>3GalNacoc 1 —>R Precursor type-3
Gaip 1 —>3GalNacP 1 —>R Precursor type 4






□ D-galactose o N-acetyl-D-glucosamine
fucose <C3 N-acetyl-D-galactosamine
R = glycolipid




Figure 1.2 Formation of H, A, B and Lewis antigens from precursor type 1.
R = glycoprotein and other symbols as in Figure 1.1.
27
1.5.5 Lewis blood group antigens
In 1946, Mourant discovered an antibody that identified a new antigen. This antigen is
called Lewisa (Lea). A few years later, Lewis^ (Le^) was discovered by Anderson
[1949]. Lea and Le^ antigens do not form part of the structure of the cell membrane
and are not synthesized on the red cells but are present in the plasma and in the body
fluids such as saliva and ovarian cyst fluid. In secretions, the Lewis determinants are
carried on the same glycoprotein molecules as the ABH antigens [Watkins, 1974], The
frequencies of the Lewis red cell phenotypes in the United States when tested with
anti-Lea and anti-Le^ are shown in Table 1.7 [Issit, 1986], This ratio can vary in
different ethnic groups and some isolated populations. Almost all American Indians
and Eskimos are secretors, and Icelanders have the highest proportion of non-secretors
(42%) [Mourant et al., 1976; Eriksson et al., 1986],
1.5.5.1 Genetics and structure of the Lewis system
The Lewis gene is located on chromosome 19 but is independent of the H and Se loci
[Elberg et al., 1983], The secretor gene contributes to expression of the Lewis blood
group antigens. Non-secretor individuals produce only Lea in their secretions. Secretor
individuals produce Le^ predominantly and variable amounts of Lea in their secretions
as well as ABH determinants on type 1 precursor chains [Race and Sanger, 1975],
Individuals who lack any Lewis determinants on their red blood cells are called Lewis
negative. The distribution of the ABO and Lewis antigens on cells and in body fluids of
secretors and non-secretors is summarized in Table 1.8
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Table 1.7 Frequencies of the Lewis phenotypes.





Table 1.8 Blood group antigens on cells and in body fluids of secretors and noa
secretors.
Secretors Non-secretors
Antigen Cells Secretions Cells Secretions
H (A/B) + + +
Le& _ (+)* _ (+)* + +
Le^ + + - -
* Present in variable quantities.
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The Lewis gene codes for an a 1-3/4 fucosyl transferase which adds L-fucose to N-
acetyl-D-glucosamine of the type 1 precursor to form Lea or to the H type 1 to form
Le^ [Oriol et al., 1986] (Fig 1.2). Lewis antigens are also found on type 2 precursors;
Lex is the equivalent of Lea and LeY the equivalent of Le^. The x gene codes for an a
1-3 fucosyltransferase that adds fucose to the subterminal N-acetyl-glucosamine on the
type 2 precursor.
1.5.5.2 Interaction between ABO, H, Se and Le genes
The genetic make up of the individual regulates the expression of the blood group
determinants through a series of glycosyl transferase enzymes acting on precursor
chains. The specificity of the glycosyl transferases will either render the end product
acceptable for another enzyme or unusable by other enzymes as a substrate. The
enzyme coded by the secretor gene adds fucose to the terminal sugar of the type 1
precursor and that coded for by the Lewis gene adds fucose to the subterminal sugar of
the type 1 precursor. If the secretor enzyme adds fucose first, the structure can act as a
substrate for the Lewis enzyme to form Le^ antigen. If the Lewis enzyme adds fucose
to the subterminal sugar first to form Lea, the secretor gene can not use the Lea as a
substrate to form Le^ [Watkins et al., 1988] (figure 1.2).
In infants, the enzyme coded by the secretor gene does not appear to be as efficient as
the one coded for by the Lewis gene. The result is that, even though they are
genetically secretors, infants express considerable amounts of Lewisa on their cells.
The relative amounts found will depend on the efficiency of the enzymes [Watkins et
al., 1988; Ogata et al., 1988].
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1.6 Hypotheses to explain the associations between
susceptibility to infectious agents and blood group
antigens and secretor status
1.6.1 Isohaemagglutinins and immune responses
Anti-A and anti-B isohaemagglutinins could act as natural bactericidal and opsonic
antibodies for some strains of microorganisms [Check et al., 1972; Muschel and
Osawa, 1959]. Reed et al. [1974] reported a significant lower proportion of group B
individuals among patients with pneumococcal disease and carriers of Strep,
pneumoniae. They have shown that pneumococci could acquire either A or B antigens
in the growth medium and with lysed bacteria they demonstrated an enzyme capable of
altering B antigen to the A-like antigen. Some of the strains tested expressed antigens
which cross reacted with A antigen. They suggested that anti-A isohaemagglutinins of
B individuals might act as natural antibodies against the bacteria. In contrast, the anti-
A and anti-B antibodies enhanced binding of N. gonorrhoea by human monocytes and
those of group B bound more bacteria than monocytes of other ABO blood groups.
This has been suggested to contribute to increased susceptibility of B blood group
individuals to gonorrhoeae [Kinane et al., 1983].
Lower levels of both salivary and serum IgA were reported for non-secretors
[Waissbluth and Langman, 1971; Grunbacher, 1972], A study by Blackwell [1989] did
not confirm this observation as no difference in total serum or salivary IgA was found
between secretors and non-secretors among carriers of N. meningitidis. Also there was
no difference between secretors and non-secretors in spondloarthropathies [Shinebaum
et al., 1987], In contrast, Zorgani et al. [1992] using the quantitative ELISA method
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found significantly higher levels of total salivary IgM and specifielgMantibodies against
N. lactamica and N. meningitidis among secretors compared with non-secretors.
1.6.2 The complement component 3 (C3) gene
Both the gene that codes for C3 and the Se gene are in the same linkage group on
chromosome 19 [Elberg et al., 1983]. In a study by Blackwell et al. [1988a] the levels
of C3 among non-secretors in non-carriers of N. meningitidis was found to be slightly
lower than those for the secretors. Lower levels of C3 and C4 complement
components were also reported among patients with insulin dependent diabetes
[Charlesworth et al., 1987], but not among sufferers of non-insulin diabetes
[Charlesworth et al., 1982]. A study by Blackwell et al. [1987] showed that there was
a significant increase in the number of non-secretors among individuals with insulin
dependent diabetes and there were lower levels of both C3 and C4 among non-
secretors [Blackwell et al., 1988b].
1.6.3 Blood group antigens: receptors for microorganisms
There are several pathogens which use blood group antigens as receptors on host cells
(Table 1.9). An association between the Duffy blood type and susceptibility to malaria
due to Plasmodium vivax has been reported [Miller et al., 1975]. Duffy antigen is
expressed in white populations but is absent in the majority of African and American
Blacks [Sanger et al., 1955]. The Duffy antigen has been demonstrated in vitro to be a
receptor for P. knowlesi which is closely related to P. vivax and this might explain why
African Blacks are more resistant to malaria infection caused by Plasmodium vivax
than the whites [Miller et al., 1975]. Barnwell et al. [1989] have shown in vitro the
Duffy antigen is a receptor for P. vivax and P. knowlesi merozoites. The P blood group
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Septicaemia and neonatal meningitis
H. influenzae type B
Plasmodium knowlesi
Blood Group receptor Reference
Lewisa May et al., 1989
P Kallenius et al., 1980
M Vaisanen et al., 1982
N Jann et al., 1988
S Korhenen et al., 1984
Anton Van alphen et al., 1986
Duffy Miller et al., 1975
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was reported to be the receptor for fimbrial adhesins expressed on strains of E. coli
often isolated from sufferers of pyelonephritis [Kallenius et al., 1980].
If ABH or Le'3 antigens act as receptors for microorganisms, these antigens in the body
fluids of secretors might bind to adhesins on the surface of microorganisms in a lectin-
like interaction and block their attachment to the cells. This hypothesis was supported
by the inhibition of attachment of Strep, salivarius to epithelial cells by salivary
glycoproteins with blood group activity [Williams and Gibbons, 1975], Also binding of
Candida to epithelial cells was inhibited by heat treated saliva from secretors but not
saliva from non-secretors [Thorn et al., 1989].
The Lea antigen found predominantly on the cells of non-secretors might be a receptor
for lectin-like adhesins of some microorganisms. The binding of uropathogenic strains
of E. coli to target cells from non-secretors was greater compared with binding to
secretor cells [Lomberg et al., 1986]. Binding of Candida blastospores to non-secretor
cells was inhibited by pretreating the cells with polyclonal anti-Lea but not anti-Le^
[May et al., 1989]. A study by Tosh and Douglas [1992] has identified an adhesin on
C. albicans that binds to fucose containing blood group antigens. The fucose binding
protein was isolated by an affinity adsorption technique and the purified protein
inhibited yeast attachment to BEC efficiently.
1.7 Aims of the study and hypothesis to be tested
The most consistent feature of SIDS is the age distribution [Carpenter and Gardner,
1982], The peak of SIDS is at 2-3 months of age then rapidly falls and the
phenomenon is rare after the first year of life. This suggests that SIDS might be
associated with a critical phase of development during which babies are at high risk
[Milliner, 1987]. One of the most remarkable characteristics of the Lewis blood group
system is the development and alteration of the phenotypes in infancy and childhood
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[Jordal, 1956], There are differences in maturation or efficiency of the products of the
secretor gene and the Lewis gene during this period in the infants' development. Lea
develops during the first postnatal weeks, its frequency of detection on red cells is
greatest 2-3 months after birth. After that age, the frequency decreases, reaching the
level found in adults from about the age of 2 years. Le^ is more uncommon in children
than in adults [Jordal, 1956], The peak incidence for detection of Lea on erythrocytes
of infants is coincident with a high incidence of SIDS (Figure 1.3) and in a study by
[Aniansson et al., 1992] nasopharyngeal colonization by S. aureus during the first
three months of life was higher than the end of the first year.
Based on epidemiological findings and laboratory investigations, the aims of this thesis
were to test the following hypothesis:
1. Lea antigen expressed on infants' cells is one of the receptors for toxigenic strains of
S. aureus and B. pertussis suggested to be involved in SIDS.










Figure 1.3 Analysis by age of expression of Lea antigen and prevalence of SIDS.
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Chapter 2
General Materials and Methods
All chemicals were analytical grade obtained mostly from BDH Chemicals Ltd.UK or
Sigma UK.
2.1 Buffers and solutions used for enzyme immunosorbent
assays (ELISA)
2.1.1 Coating buffer (carbonate-bicarbonate buffer)
Coating buffer consisted of sodium carbonate (15 mM), sodium bicarbonate (35 mM)
and sodium azide (3 mM) (pH 9.6).
2.1.2 Phosphate buffered saline (PBS)
PBS contained sodium chloride (15 mM), sodium orthophosphate (3.7 mM) and
disodium hydrogen phosphate (9.6 mM) (pH 7.2).
2.1.3 Washing buffer
Washing buffer consisted of (0.1 % w/v) bovine serum albumin (BSA) and (0.05 %
v/v) Tween-20 in PBS (pH 7.2).
2.1.4 Blocking buffer
Blocking buffer was prepared by adding (1 % w/v) BSA to PBS.
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2.1.5 Phosphate citrate buffer
Phosphate citrate buffer contained sodium hydrogen phosphate (0.1 M) and citric acid
(0.1 M) (pH 5).
2.1.6 Substrate solution
The substrate was prepared by adding 40 mg of O-phenylenediamine to 100 ml of 0.1
M phosphate citrate buffer. It was activated immediately before use with 40 pi of
hydrogen peroxide (30 % v/v).
2.1.7 Stopping solution
The stopping solution is made of 12.5% (v/v) H2SO4.
2.2 Buccal epithelial cells (BEC)
BEC were obtained from healthy students and staff (age range 20-64) in the
Department of Medical Microbiology, University of Edinburgh. BEC were collected by
gently scraping the lining of the mouth with cotton swabs. The swabs were agitated in
(10 ml) of PBS. The cells were washed twice with PBS in a Sorval RT 6000 centrifuge
at 300 g for 10 min. The BEC were counted with a Neubauer haemocytometer and
their concentration was adjusted to 2 x 10^ cells per millilitre.
2.3 Collection of saliva
Saliva (20 ml) was collected from the same individuals whose BEC were used. The
saliva was centrifuged at 1000 g for 15 min. The supernates were transferred to glass
universal containers and boiled for 30 min, centrifuged again and stored at -20°C.
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2.4 Determination of ABO blood group
The ABO blood group of the individuals were determined from finger prick blood
specimens by slide agglutination with monoclonal anti-A and anti-B antibodies from
the Scottish National Blood Transfusion Service, (SNBTS).
2.5 Determination of secretor status
Secretor status was determined from a saliva specimen of each donor by
haemagglutination inhibition assays [Mollison, 1983], Saliva (25 p,l) prepared in 2.3
was added to 25 jal of 3 appropriate dilutions of anti-A or anti-B (SNBTS) and 2
dilutions of the Ulex europaeus lectin (Sigma) in V-well micro-titre trays. The saliva of
a non-secretor and of a secretor were included as controls. The plates were incubated
at room temperature (RT) for 30 min after which the appropriate blood cells O, A1
mix or B (25 |J,1) (SNBTS) diluted 1/5 in saline were added to the wells. They were
incubated at RT for 2 h or overnight at 4°C and examined for agglutination.
2.6 Determination of Lewis phenotype of erythrocytes
Saline (2 ml) was added to 20 p.1 of blood in a Falcon test tube and centrifuged at 300
g for 5 min. The supernatant was taken off and 40 p.1 of saline was added to the test
tube. The cells (20 jil) were added to 20 p.1 of anti-Lea (SNBTS) and 20 jil to an equal
amount of anti-Le^ (SNBTS). The tubes were incubated at RT for 30 min and
observed for agglutination.
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2.7 Purification ofmonoclonal anti-Lewisa and anti-Leb
Synsorb affinity adsorbent (Chembiochem Ltd., Edmonton, Canada) with the synthetic
carbohydrate determinant of Lea or Le^ covalently linked to the silica matrix was used
to purify the anti-Lea and anti-Le^ monoclonals. Hybridoma culture supernatant (20
ml) containing mouse anti-Lewisa antibody (LM 112/161) or anti-Le^ (LM 112/81)
antibodies (kindly provided by Dr. R. Fraser, Glasgow and West Scotland Blood
Transfusion Service, Law Hospital, Carluke, Lanarkshire, UK) was mixed with 1 g of
the corresponding Synsorb beads overnight at 4°C. The unbound antibodies were
removed and the beads were washed twice with PBS by centrifugation at 50 g for 5
min. The bound material was eluted by adding 5 ml of 2% (v/v) ammonia (BDH,
35%) in saline (pH 11) to the beads for 15 min at RT and centrifuged at 50 g for 5
min. The supernatant was dialysed against PBS overnight and stored at - 20°C. The
washed beads were stored in ethanol (70 % v/v) at 4°C.
2.8 Bacteria
S. aureus strains used in this study, the toxins they produce and their site of isolation
are listed in Table 2.1. National Culture Type Collection (NCTC) strains NCTC
10652, NCTC 10654, NCTC 10655, NCTC 10656, NCTC 10657, NCTC 11965 and
NCTC 8532 were obtained from Dr. A. Wieneke, Central Public Health Laboratory,
Colindale. Strains 40654 and 41206 were kindly provided by Dr. J Medcraft, Public
Health Laboratory Service, Department of Microbiology, Reading, Berkshire.
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Table 2.1 Toxins produced and source of S. aureus
Strain number Toxin produced Source
NCTC 8532 None Not known
NCTC 10652 Ham





NCTC 10657 A and B Not known
NCTC 11965 AandTSST-1 Vaginal swab
40654 Nose
41206 B Post-mortem lung tissue
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2.8.1 Culture media and storage of bacteria
The bacteria were grown on nutrient agar plates or, for some experiments, on blood
agar plates to examine the effect of medium on binding of bacteria to epithelial cells.
They were incubated in a humidified aerobic atmosphere with 5% CO2 for 24h at
37°C. For storage, colonies were emulsified in Microbank beads and kept at -20°C. A
fresh bead was used to inoculate plates for each set of experiments.
2.8.2 Preparation of bacteria
S. aureus strains were subcultured as described (2.8.1) and colonies were emulsified in
10 ml of PBS and centrifuged at 1000 g for 20 min. The bacterial pellet was
resuspended in 2 ml of PBS.
2.8.3 Total bacterial count
After measuring the optical density (OD) of two fold dilutions of the washed
suspension for each strain at 540 nm with a spectrometer (Pye Unicam), the total
number of bacteria was determined in a counting chamber (Thoma) by light
microscopy. A graph of the OD versus total count was prepared for each strain.
2.9 Buffers used for determination of bacterial binding to
buccal epithelial cells
2.9.1 Fluorescein isothiocyanate (FITC) buffer
The buffer contained sodium carbonate (0.05 M) and sodium chloride (0.1 M) (pH
9.2). FITC (0.4 mg/ml)(Sigma) was dissolved in the buffer immediately before use.
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2.9.2 Buffered paraformaldehyde
Buffered paraformaldehyde (1% v/v) was prepared by adding paraformaldehyde
(BDH, 97%) to sodium cacodylate (1% w/v) and sodium chloride (0.75% w/v).
2.10 Bradford reagent for protein estimation
Bradford reagent was prepared from Commasie Blue G250 (0.01% w/v) (Sigma),
ethanol (4.7% w/v) and phosphoric acid (8.5% w/v) in distilled water.
2.11 Monoclonal and polyclonal antibodies
Monoclonal and polyclonal antibodies, the animal from which they were obtained,
isotype and source are listed in Tables 2.2 and 2.3.
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Table 2.2 Monoclonal antibodies
Monoclonal antibody Host Isotvpe Source
Anti-A mouse IgG SNBTS
Anti-B mouse IgG SNBTS
Anti-Lea (Red cell typing) mouse IgM SNBTS
Anti-Lea (Inhibition of bacterial binding) mouse IgM SAPU
Anti-Leb (Red cell typing) mouse IgM SNBTS
Anti-Le^ (Inhibition of bacterial binding) mouse IgM SAPU
Anti-precursor type 1 mouse IgM Russel Fine Chemicals,
Chester.
Anti-CD 15 (anti-Lex) mouse IgM Serotec
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Binding of Staphylococcus aureus to BEC of
secretors and non-secretors
3.1 Introduction
S. aureus is part of the normal flora inhabiting the nasopharynx and the oropharynx of
a significant proportion of healthy humans [Rosebury, 1962], Adherence of S. aureus
to epithelial cells is achieved partly by non-specific mechanisms; the electric charge and
hydrophobicity of bacterial cell walls vary during growth of S. aureus and influence
their adherence to epithelial cells [Beck et al., 1988]. In addition, there are specific
"lock and key" bonds between complementary molecules on cell surfaces of the host
and the bacteria. S. aureus cell wall components, teichoic acids and protein A, have
been implicated in adherence [Cole and Silverberg, 1986; Wyatt, 1990], Teichoic acids
bind specifically to nasal epithelial receptor sites for S. aureus [Aly et al., 1980], and
lipoteichoic acid mediates adherence of S. aureus to BEC [Carruthers and Kabat,
1983], The epithelial cell receptors for S. aureus are poorly understood; however,
results indicate that the preferential attachment of S. aureus to endothelial cells is
mediated by fibrinogen absorbed from plasma on to the endothelial surface [Cheung et
al., 1991]. Sites at which S. aureus typically initiates infection are rich in fibronectin,
for example blood clots and sub-endothelium [Proctor, 1987].
Epidemiological studies have found that individuals who are non-secretors of the ABO
blood group antigens are over-represented among patients with some bacterial diseases
and among carriers of some potentially pathogenic bacteria. One hypothesis suggested
• ... Q
to explain these epidemiological associations is that the Le blood group antigen
expressed predominantly on the cells of non-secretors is one of the receptors for some
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strains of bacteria. During the age range (2-4 months) in which the peak incidence of
SIDS occurs, 80-90% of infants express Lea (Figure 1.3). The objective of this study
was to develop a reliable method for assessment of bacterial binding and to test the
hypothesis that toxigenic strains of S. aureus isolated from SIDS infants bind in greater
numbers to cells from non-secretor donors which express more Lea than cells from
secretor donors.
3.2 Materials and methods
3.2.1 Epithelial cells
Buccal epithelial cells were obtained from pairs of healthy secretor and non-secretor
donors matched as closely as possible for ABO blood groups, age and sex. The cells
were washed and adjusted to 2 x 10^ cell / ml as described in (2.2).
3.2.2 Labelling of S. aureus with FITC or rhodamine
Bacteria were labelled with FITC by a modification of the method of Wright and Jong
[1986]. A heavy suspension of bacteria was prepared and washed twice by
centrifugation at 1000 g for 20 min. The bacterial pellet was resuspended in 4 ml of
freshly prepared FITC (2.9.1). The mixture was incubated at 37°C for 20 min and
washed twice with PBS. The pellet was resuspended in PBS and filtered through a
Millipore membrane filter (5 pm pore diameter) and the concentration adjusted by OD
at 540 nm (2.8.3).
Rhodamine 123 (Sigma, UK.) was also used to label the bacteria. Rhodamine (1 mg/
ml PBS) (2 ml) was added to a pellet of S. aureus and incubated for 20 min at RT. The
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bacteria were washed twice in PBS, filtered and the concentration adjusted as
described for the FITC labelling procedure.
3.2.3 Methods for detection of the attachment of S. aureus
to BEC
3.2.3.1 Light Microscopy
A binding assay described by [Bagg et al., 1982] was used. Samples of a suspension of
S. aureus strain NCTC 10655 (2 x 10 /ml) were mixed with equal volumes of a buccal
cell suspension (2 x 10^/ml) in glass universal tubes. They were rotated at 30 rpm at
37°C for 45 min; each mixture was filtered through a Millipore membrane filter (5 pm
pore size) to remove the unbound bacteria. Each filter was washed with 50 ml of PBS
and inverted onto a drop of PBS on a microscope slide. The filters were removed after
2 min. The slides were air-dried, fixed in methanol for 5 min and finally stained by
Gram's stain. Bacterial counting was performed at a magnification of 400 under oil
immersion.
3.2.3.2 Detection of bacterial binding to BEC by Confocal
Scanning Optical Microscopy (CSOM)
S. aureus strain NCTC 10655 was used in this study. BEC (200 pi) were mixed with
200 pi of the FITC-labelled bacteria at different ratios of bacteria per cell. The
mixtures were incubated at 37°C for 30 min with gentle shaking at 60 rpm in an orbital
incubator (Gallenkamp). The cells were washed twice with PBS by centrifugation at
300 g for 10 min to remove unattached bacteria and resuspended in 200 pi of PBS and
200 pi of 1% (v/v) buffered paraformaldehyde then stored in the dark at 4°C until
analysed. In-order to remove the salt crystals seen under the microscope, the cells were
washed once more with distilled water before the analysis.
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Dry and wet preparations were examined by CSOM. To select suitable cells, a field
was first scanned at low magnification with transmitted white light; ultraviolet (UV)
light was then used to identify cells which had bound FITC-labelled bacteria. Images of
individual cells obtained at a magnification of 1600 by reflected white light were saved
on the hard disc. The fluorescence mode was again selected (488 nm argon ion laser)
and images obtained in this mode were saved. Coloured overlays of the two sequences
of images were then made and photographed. Finally a series of 45 optical sections of
single cells, "cut" at 1 |Lim intervals were downloaded to a silicon graphics workstation
allowing 3-dimensional (3D) representations of the cell to be made by the programme,
Voxel View. Each cell could be surveyed from any direction; the surface to which
bacteria were bound could then be identified with precision.
3.2.3.3 ELISA to detect bound bacteria with antibody
A modified method of Morrin and Reen (1993) was used. Samples of washed BEC in
PBS were added to a microtitre plate. The monolayer of buccal epithelial cells (2x10^)
was dried on to the plates overnight at 37°C and fixed by treatment with
glutaraldehyde (Sigma) 0.25 % for 10 min. The wells were washed 3 times with PBS.
Suspensions of S. aureus strain NCTC 10657 grown on nutrient agar plates for 24 h
were added at ratios of 640 and 1280 bacteria per BEC and incubated for 1 h at 37°C.
After washing 3 times with PBS, the cells were fixed with glutaraldehyde and blocked
by BSA. The BSA was removed and bound S. aureus were detected with rabbit anti-
staphylococcal enterotoxin B (Sigma, S 9008) diluted 1/500 in PBS. The antibody was
allowed to react for 1 h at RT. After washing, 100 pi of FIRP-labelled anti-rabbit IgG
(SAPU) diluted 1/250 in PBS were added to the wells and incubated for 2 h at RT.
The wells were washed with PBS and 50 pi of the substrate solution (2.1.6) were
added. The reaction was stopped after 20 min by adding 50 ul of 12.5% ( v/v )
H2SO4. The optical density at 450 nm was measured with a Dynatech plate reader.
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For the controls PBS was added in place of the anti-staphylococcal enterotoxin B or
PBS was added in place of bacteria.
3.2.3.4 Analysis of binding assays by flow cytometry
The binding studies were carried out with FITC-labelled or rhodamine 123-labelled
staphylococci (3.2.2).
BEC (200 p,l) were mixed with 200 |il of the labelled bacteria at the desired ratios of
bacteria per cell. The mixtures were incubated at 37°C for 30 min with gentle shaking
in an orbital incubator (Gallenkamp). The cells were washed twice with PBS by
centrifugation at 300 g for 10 min to remove unattached bacteria. The samples were
resuspended in 300 pi of buffered paraformaldehyde (Sigma) and EPICS C flow
cytometer (Coulter Electronics, Ltd) was used in these studies. BEC were selected
from a display of forward angle light scatter which is proportional to the size of the
particle versus 90° light scatter which is proportional to the granularity of the particle
by means of a bit map. The bit map included the main population of the cells and
excluded debris and clumps from further analysis. At least 2000 BEC were analysed in
each sample. The percentage of fluorescence in a FITC-labelled sample was assessed
with reference to a cursor placed in a channel where less than 2% of the cells in an un¬
labeled sample were positive. The percentage of cells with fluorescence greater than
the background was recorded on a one-parameter histogram, measuring fluorescence
on a logarithmic scale. The mean fluorescence channel values for the positive cells
were obtained from a one-parameter histogram measuring, fluorescence on a linear
scale.
The results were analysed by immunoanalysis (Coulter), a computer programme that
subtracts the values of the control population from the test population at each channel
of the two histograms. The binding index (BI) for each sample was calculated by
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multiplying the percentage of fluorescent cells by the mean fluorescence channel value.
This index of total fluorescence in a sample gives an indication of the FITC-labelled
staphylococci bound to the BEC.
3.2.4 Statistical methods
All analyses were carried out on the logarithms of the binding indices which conformed
more closely to a normal distribution than the raw values. Differences between groups
were tested by paired t-test as appropriate and confidence limits for the mean values in
one group were expressed as a percentage of those in the other by taking
antilogarithms.
3.3 Results
3.3.1 Correlation of total bacterial count with optical
density
The correlation between the readings of OD with the total bacterial count (2.8.3) for










Figure 3.1 Total bacterial count (X 10"^) determined by microscopy versus
optical density of S. aureus strains tested.
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3.3.2 Light microscopy
Binding experiments with S. aureus at 3 different ratios (100, 400 and 1200) of
bacteria per cell were assessed by light microscopy. Bacteria were not evenly
distributed over the epithelial cells. The untreated epithelial cells used as control
revealed many structures, the shapes and sizes of which could be mistaken for bacteria.
Forty cells were counted on each slide. The data from duplicate slides were highly
variable and there did not appear to be a correlation between the ratios of bacteria used
and the number of bacteria observed attached to the cells (Table 3.1).
3.3.3 Confocal Scanning Optical Microscopy
CSOM has the ability to superimpose two images of the same object one with and one
without the laser mode. The number of bacteria bound to cells was related to the
concentrations of bacteria used, 640:1 and 2560:1 (Figure 3.2 and Figure 3.3)
Variations in the number of bacteria bound to cells were also evident for each
concentration. A 3 dimensional view of the epithelial cell clearly demonstrated that the
bacteria were attaching to its surface (Figure 3.4).
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Table 3.1. The mean of number of bacteria per cell counted by light microscopy.







BEC without bacteria 0 24
* Too numerous to count
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Figure 3.2 Detection of FITC-labelled S. aureus NCTC 10655 on BEC (640 B/C).
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Figure 3.3 Detection of FITC-labelled S. aureus NCTC 10655 on BEC (2560
B/C).
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Figure 3.4 Three dimentional image of FITC-labelled bacteria on the surface of
BEC.
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3.3.4 ELISA to detect bound bacteria
S. aureus strain 10657 produces enterotoxins A and B. Rabbit anti-staphylococcal
enterotoxin B was used to detect the bound bacteria. Both FITC-labelled and
unlabelled bacteria were used. Two controls were included. One without bacteria and
one without the anti-toxin B. The mean of 3 values for the labelled and unlabelled
bacteria were similar for the 2 concentrations of the bacteria used, but there was
significant binding of the antibody to cells to which no bacteria were added. This
indicated that anti-toxin binds to structures on the BEC or to commensal bacteria
(Table 3.2).
If the background for the cells with no bacteria (0.400) was subtracted from the values
for cells to which bacteria were added, the results showed a dose response pattern with
greater OD values for 1280 bacteria / cell (0.220, 0.217) compared with 640 bacteria /
cell (0.120, 0.136).
3.3.5 Analysis of bacterial binding by flow cytometry
3.3.5.1 Labelling of S. aureus
The peak in Figure 3.5b is an example of fluorescence observed for cells to which
FITC-labelled bacteria are bound compared to control cells with no labelled bacteria
Figure 3.5a. The binding indices for S. aureus labelled with FITC was much higher
than those for cells with rhodamine 123. The results of one experiment in which both
fluorochromes were used separately to label S. aureus (NCTC 10655) and added to
BEC at ratios of 75, 150, 300 and 600 bacteria / cell are shown in Figure 3.6.
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Table 3.2 Mean OD values for ELISA with anti-enterotoxin B to detect bacterial
binding.









Figure 3.5 Flow cytometric analysis of bacterial binding to BEC using FITC
conjugated bacteria (b) compared to cells with no bacteria (a).
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Fig 3.6 Binding indices for FITC or rhodamine labelled S. aureus bound to BEC.
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3.3.5.2 Optimal time for bacterial binding
Different concentrations of FITC-labelled bacteria were incubated with BEC for
different time periods and the attachment study was performed as described in 3.2.3.4.
No fluorescence above background levels was observed when bacteria were added to
BEC immediately prior to analysis. Attachment increased for the first 30 min then the
increase was less rapid as is shown in Figure 3.7 As the attachment was adequate at 30
min, this was used as the standard incubation period for the binding assays.
3.3.5.3 Bacterial binding at different ratios of bacteria/cell
Attachment of S. aureus (Strain 10655) to BEC was examined with six different ratios
of bacteria per cell (40, 80, 160, 320, 640, or 1280 : 1). Fig 3.8 illustrates the dose
response effect of bacterial binding to cells from both a secretor and a non-secretor
individual. Bacterial attachment was evident from 80 bacteria per cell and ratios of 80,
160, 320 and 640 bacteria per cell were used for further experiments. Fig 3.9 presents
the binding of 4 strains of S. aureus to epithelial cells of the same donor. Similar
patterns were observed with other strains.
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Time (minutes)
Figure 3.7 Time course of binding for S. aureus (NCTC 10655) to BEC (% is the
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No. of B/C
Figure 3.8 Dose response of S.aureus (NCTC 10655) binding to BEC.
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Figure 3.9 Binding of four strains of S. aureus (41206, NCTC 8532, NCTC 11965
and NCTC 10655) to BEC of the same donor (B/C = bacteria / cell).
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3.3.6 Binding of S. aureus strains to BEC from secretors
and non-secretors
Eight pairs of secretors / non-secretor donors were used for each experiment. In
(Figures 3.10-3.18) the data are presented as a difference in the percentage of the
binding (binding indices) between secretor and non-secretor cells, each point
representing the results for one pair of donors. If there was no difference the point is
on the line (0%). The points above the line represent those pairs in which the non-
secretor cells bound more bacteria than cells from the secretor. The points below the
line represent those pairs in which the secretor cells bound more than those from the
non-secretor. There was no significant difference in binding to cells of non-secretors
compared to cells of secretors observed for the non-toxigenic strain NCTC 8532
(Figure 3.10) or five of the toxin producing strains: NCTC 41206 (Figure 3.11);
NCTC 40654 (Figure 3.12); NCTC 10652 (Figure 3.13); NCTC 10654 (Figure 3.14);
or NCTC 10656 Figure (3.15). Three of the toxin producing strains, NCTC 10655,
NCTC 10657 and NCTC 11965, showed higher binding to cells from non-secretors
compared with binding to cells from secretors (Figures 3.16, 3.17 and 3.18). There
was significantly higher binding of NCTC 10655 and NCTC 10657 to non-secretors'
cells at all ratios of bacteria: cells tested; for strain NCTC 11965, there was
significantly higher binding to cells of non-secretors only with the lowest ratio of
bacteria.
Table 3.3 summarises the results for the strains tested by the paired t test. The 95%
confidence limits for binding of the bacteria to non-secretor cells are expressed as a
percentage of binding to cells from matched secretors. The confidence intervals for
which both values are above 100 indicated significantly higher binding of bacteria to











































































































































































Figure 3.18 Binding of S. aureus (NCTC 11965) to epithelial cells of secretors and
non-secretors.
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Table 3.3 95% confidence limits for binding of S. aureus to non-secretor cells
expressed as a percentage of binding to cells from matched secretors.
Strain 80 Bacteria : cell 160 Bacteria : cell 320 Bacteria : cell
NCTC 8532 66- 145 69 -146 31 - 182
NCTC 10652 63 - 198 63 -227 50- 301
NCTC 10654 67 - 153 75 - 185 75 - 206
NCTC 10655 138 -228** 107 - 249* 107 -237*
NCTC 10656 61 - 136 79 - 175 67 - 178
NCTC 10657 110-197* 101 - 161* 117- 165**
NCTC 11965 102-201* 92-192 81 -203
40654 82- 182 54- 189 91 -222
41206 74-147 75- 172 74- 158
*
p < 0.05; ** p < 0.01
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3.4 Discussion
The objective of this study was to test the hypothesis that epithelial cells from non-
secretor donors bind greater numbers of toxigenic staphylococci than cells from
secretors. BEC were chosen for the study of the binding assays because of their ready
availability and their interaction with bacteria will mimic the natural system in vivo.
Although many cells are dead and there are variations in size of the cells, they have
been used for binding assays with many bacterial species: type III Group-B
Streptococci pyogenes [Bagg, 1982], Neisseria meningitides [Craven and Frasch,
1978] and S. aureus [Beck, 1989].
A number of different techniques were used to measure the attachment of bacteria to
cells. There were several problems associated with the light microscopy method for
assessment of bacterial binding. Bacteria were not evenly distributed over the BEC.
There were background commensal organisms which affected the counting of bound
bacteria and the number of bacteria observed varied greatly. Similar variability has
been observed by Anderson et al. [1981], It is a very laborious experiment because at
least 40 cells must be counted for each test or control sample. CSOM was useful to
confirm the bacteria were bound to cells. Although the FITC dye distinguished the
staphylococcal test strain from commensal bacteria, it is time consuming to do the
counting for a reasonable number of cells, and CSOM is an expensive technique.
ELISA was used to detect bacteria bound to epithelial cells. Both the FITC-labelled
and un-labelled bacteria were used. The OD values for both the labelled and the un-
labelled cells were close, but there was a high OD reading for the control to which no
bacteria had been added, probably due to anti-toxin binding to molecules on BEC or to
the commensal bacteria. When the background was subtracted, there appeared to be a
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correlation between the number of bacteria added and the OD reading for both FITC
labelled and unlabelled S. aureus.
Flow cytometry provided a potentially powerful tool for analysing bacterium-cell
interactions. It is a reliable and practical method. Large numbers of cells were analysed
in a short period of time. Dyes such as fluorescein isothiocyanate (FITC) that bind
covalently to protein amino groups are preferable to other acid dyes because washing
lowers background fluorescence [Shapiro, 1990]. Direct labelling of bacteria with
FITC was used for adhesion assays by other workers [Svenson and Kallenius 1983],
Direct labelling of S. aureus with FITC was the method chosen for these studies.
Rhodamine 123 which binds to the mitochondria has been used to stain bacteria
[Kaprelyants, 1992], The binding indices obtained with FITC-labelled S. aureus were
much higher than those obtained with rhodamine 123 (Fig 3.5). The binding of S.
aureus to BEC was rapid and saturable. There was adequate binding at 30 min (Fig
3.6), and the binding was clear at ratios of 80-640 bacteria / cell. There was not much
variation in the binding index when different ratios of 4 strains of S. aureus were used
for binding with cells from one donor (Fig 3.8).
Non-secretors of ABO blood group antigens are over-represented among carriers of
group A streptococci [Haverkorn and Goslings 1969], and because density of
colonization might be an important consideration in the hypothesis that toxin
producing bacteria play a role in some cot deaths we tested the hypothesis that
epithelial cells from non-secretor donors bind greater numbers of toxigenic
staphylococci than cells from secretors. The results in Table 3.3 indicated variations in
the results of binding indices among both the secretors and the non-secretors. The
source of BEC was dependent on the availability of the individuals during the day of
the test; therefore, BEC were not always from the same individuals for the various
strains tested. The results also indicated that 3 of the 8 toxigenic strains, including one
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producing TSST-1, bound in significantly greater numbers to non-secretor cells (Fig
3.16, 3.17 and 3.18). The 5 remaining toxigenic strains and the non-toxigenic strain
showed no difference in binding to cells of secretors compared with non-secretors (Fig
3.10, 3.11,3.12, 3.13, 3.14 and 3.15).
The results indicated either that different individuals express different amount of Lea
on their epithelial cells or the adhesins which recognise Lea molecules are found only
on the 3 strains which showed the higher binding to cells from non-secretors. These
two possibilities are the subject of the next chapter.
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Chapter 4
Determination of Lewisa antigen on BEC and its
possible role as a binding site to S. aureus
adhesins
4.1 Introduction
The results in chapter 3 indicated that only three strains of toxigenic S. aureus bound
to cells from non-secretors in greater quantities than cells from secretors, hence two
explanations were proposed. First, there might be variable amounts of Lea on the cells
of secretors. Second the adhesins that bind Lea were present only on the three strains
which bound more to cells from non-secretors.
Non-secretors can produce only Lea while secretors produce predominantly Le^ and
also variable amount of Lea [Race and Sanger, 1968]. The production of Lewis
substances is due to the competition between two fucosyl transferases, one coded for
by the secretor gene (Se) and one coded for by the Lewis gene (Le). Both these
enzymes add fucose to the type 1 precursor chain from which most of the ABO and
Lewis antigens in secretions are derived (Chapter 1). If the secretor transferase adds
fucose to the terminal sugar in the precursor chain, the Lewis enzyme can add fucose
to the sub terminal sugar to produce Le^. If the Lewis enzyme adds fucose to the sub-
terminal sugar first to produce Lea, the secretor enzyme cannot use this structure as a
substrate and Lea is the final product [Watkins et al., 1988], The relative amounts of
Lea present in a secretor will depend on the efficiencies of the two enzymes. If the
secretor enzyme is more efficient, most of the type 1 precursor chain will be present as
Le^. If the Lea enzyme is more efficient, there will be relatively more Lea. Non-
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secretors can produce only Lea as they lack the transferase coded for by the secretor
gene.
May et al. [ 1989] have shown that pre-treatment of BEC of a non-secretor donor with
monoclonal anti-Lea will significantly inhibit the binding with Candida blastospores. If
the adhesins that bind Lea were present only on those strains that bound in greater
amounts to cells of non-secretors, it was predicted that their binding to BEC could be
reduced by pre-treatment of the cells with monoclonal anti-Lea. Binding of strains that
did not express the Lea adhesin (e.g. NCTC 8532) would be unaffected by pre-
treatment of the cells with the antibody.
The objectives of this part of the study were:
1. To assess levels of Lea on BEC of secretors and non-secretors by detection of
binding of monoclonal anti-Lea to the cells.
2. To test the hypothesis that attachment of S. aureus NCTC 10655 that bound in
greater numbers to cells of non-secretors could be reduced by pre-treatment of the
cells with anti-Lea, but that binding of NCTC 8532 would not be affected by this
treatment.
4.2 Materials and methods
4.2.1 Detection of Lea and Leb on erythrocytes
The Lewis red cell phenotype of all secretors and non-secretors tested was determined
by tube agglutination test as described in (2.6)
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4.2.2 Detection of Lea and Leb antigens in saliva of
secretors and non-secretors
An ELISA was used to detect Lea and Le^ blood group antigens in saliva. Synsorb
purified monoclonal anti-Lea diluted 1/25 (100 pi) or anti-Le^ diluted 1/10 (100 pi) in
coating buffer was added to wells of polystyrene microtitre plates (Dynatech,
Billinghurst, Sussex) and incubated overnight at 4°C. The wells were washed 3 times
in washing buffer and blocked by 100 pi of blocking buffer. The plates were washed 3
times and 100 pi of each saliva specimen diluted 1/10 in PBS were added to the wells
(At 1/10 dilution of saliva, the absorbence was higher than with the neat saliva because
saliva contains mucus and other proteins). The plates were incubated at RT for 60 min
and washed 3 times. Polyclonal goat anti-Lea antibody (Behring, 100 pi diluted 1/25)
or polyclonal goat anti-Le^ antibody (Behring, 100 pi diluted 1/25) was added to the
appropriate wells and incubated for 60 min. The plates were washed and 100 pi of
horseradish peroxidase-conjugated donkey anti-goat immunoglobulin (1/250) were
added for 2h at RT. The plates were washed and 50 pi of the substrate (section 2.1.6)
were added. After incubation for 20 min at RT, the reaction was stopped by adding 50
pi of stopping solution (section 2.1.7) to each well. Absorbence at 490 nm was
measured with a Dynatech plate reader. The readings for duplicate samples were
averaged.
4.2.3 Detection of Lea, Leb, type 1 precursor and Lex
antigens on EEC of secretors and non-secretors
BEC (200 pi, 2 x 10^ ml~l) were added to Falcon tubes containing 200 pi of
monoclonal antibodies to Lea (1/5, SAPU), Le^ (1/10, SAPU), precursor-type 1 (1/10,
Russel Fine Chemicals) or Lex (1/10, serotec). The tubes were incubated at RT for 60
min, washed twice with PBS at 300 g for 10 min and incubated with 200 pi rabbit anti-
mouse IgM conjugated with FITC (1/200, sigma). The FITC-labelled antibody was
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also added to 200 |Lil of cells which had not been treated with the first antibody as a
control. The tubes were incubated at 37°C for 60 min with continuous shaking. The
cells were washed twice with PBS and fixed with 200 pi of 1% buffered
paraformaldehyde and stored in the dark at 4°C until analysed. The cells were analysed
on an EPICS-C flow cytometer (3.2.3.4).
4.2.4 BEC adsorption of Lea from non-secretor saliva
Serial dilutions (200 pi) of fresh unboiled saliva from a non-secretor were added to
200 pi of a suspension of BEC (2 x 10^ cells / ml) from a Lea~b~ individual and from a
non-secretor individual. Neat saliva (200 pi) from the Lea~b- donor was added to cells
as a control. The effect of boiled saliva was also tested. The tubes were incubated at
RT for 60 min, washed twice in PBS and the binding of anti-Lea to the treated and
untreated cells detected by the flow cytometer method described in 4.2.3.
4.2.5 Inhibition of bacterial binding by pre-treatment of
BEC with monoclonal anti-Lea, anti-Lex or anti-
precursor type 1
BEC obtained from secretors and non-secretors (200 (il) were incubated with 200 pi
of monoclonal anti-Lea (SAPU), anti-precursor type 1 (Russel Fine Chemicals) or anti-
Lex (Serotec) at 37°C for 60 min. After washing twice by centrifugation at 300 g for
10 min, the attachment assays with FITC-labelled NCTC 10655 and NCTC 8532 were
performed and analysed as described in (3.2.3.4).
4.2.6 Statistical methods
All analyses were carried out on the logarithms of the binding indices which conformed
more closely to a normal distribution than the raw values. Differences between groups
84
were tested by paired or un-paired t tests as appropriate, and confidence limits for the
mean values in one group were expressed as a percentage of those in the other by
taking antilogarithms. Analysis of covariance was used to test whether binding levels
were associated with the amount of anti-Lea in secretors and non-secretors tested on
different days, while the association in a similar experiment with anti-precursor type 1
on a single day was tested by the Pearson correlation.
4.3 Results
4.3.1 Detection of Lea and Leb on erythrocytes
The secretor status of the donors was determined by the haemagglutination inhibition
assays. The results of tube agglutination tests were positive with anti-Lea and negative
with anti-Leb with erythrocytes from individuals classed as non-secretors by the
haemagglutination inhibition assay with their saliva. Cells from secretors were
agglutinated by anti-Le^ except for two secretors (out of 12 donors) whose cells were
not agglutinted by either anti-Lea or anti-Le^.
4.3.2 Detection of Lea and Leb in saliva by ELISA
Uniformly high readings were obtained with the saliva of nine non-secretors in the
ELISA for Lea antigen, with OD ranging from 1.322 to 1.752. The OD for Le^ values
were low (< 0.1) in all except for one which was (0.180) (Fig 4.1). There were variable
results for both Lea and Le^ jn saliva of 10 secretors whose erythrocytes were
agglutinated by anti-Le^. There were very low OD readings (< 0.050) for both Lea and
Le^ with saliva from donors 1 and 2 whose erythrocytes were not agglutinated with








Fig 4.2 OD values for detection of Lea and Le^ in saliva of secretors.
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4.3.3. Detection of Lea on EEC
4.3.3.1 Titration of FITC anti-mouse antibody and of anti-
Lea
Serial dilutions of FITC anti-mouse IgM in PBS (200 |il) were added to BEC (200 |il)
to choose the appropriate concentration at which non-specific binding was minimal.
The 1/200 dilution showed low fluorescence readings and was used for the assay.
The optimal dilution of anti-Lea was determined by the method described in (4.2.3)
with serial dilutions of anti-Lea. The 1/5 dilution was chosen for the assays as a high
percentage of cells of non-secretors were positive compared with much lower readings
for cells from Lewis negative donors (Table 4.1).
4.3.3.2 Binding of anti-Lea to buccal epithelial cells of
secretors and non-secretors
The buccal epithelial cells (BEC) from the individuals whose erythrocytes were not
agglutinated by either anti-Lea or anti-Le^ (Lea~b- or Le-negative) bound low levels of
anti-Lea. Cells from non-secretors bound high levels of the antibody, both in the
percentage and mean values. While the mean binding index for secretors (36707) was
approximately half that for non-secretors (79148), there was considerable variation in
the amount of antibody bound by individual secretors, both in the percentage and mean
values (Fig 4.3). The average value for binding index for a non-secretor was 16 times
more than for Lea_b" individual and this low value could be non-specific.
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Figure 4.3 Binding of monoclonal anti-Lewisa to BEC from 2 Le-negative
secretor, 8 secretor and 7 non-secretor donors.
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4.3.4 Binding of anti-Lewis*5 to BEC
Serial dilutions of anti-Le^ in PBS were used to detect Le^ on BEC. At the 1/10
dilution, the percentage of binding obtained with cells of a secretor donor was high;
however at this concentration there was significant fluorescence with cells from a non-
secretor (Fig 4.4). The cross reactivity was more obvious when BEC from four
secretors, four non-secretors and two Lea"^" were tested for binding of anti-Le^ (Fig
4.5)
4.3.5 Binding of anti-precursor type 1 to BEC
The optimal dilution for the monoclonal anti-precursor type 1 was 1/10 (Fig 4.6) and it
was used for further experiments. There was no consistent pattern of binding of the
anti-precursor monoclonal to cells of secretors, non-secretors or Lewis-negative
individuals (Fig 4.7).
4.3.6 Binding of anti-Lewisx to BEC
The optimal dilution for monoclonal anti-Lex was 1/10 (Fig 4.8). The binding indices
for anti-Lex were lower than those for anti-Lea when tested with cells from the same
donors. There was no correlation between binding of anti-Lex and anti-Lea to cells
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Figure 4.4. Titration of anti-Lewis against BEC of secretor, non-secretor and
Lewis negative donor.
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Figure 4.5 Binding of monoclonal anti-Lewis'5 (1/10) to BEC from 2 Lewis
negative secretors, 4 non-secretors and 4 secretor donors.
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Figure 4.7 Binding of monoclonal anti-precursor type 1 (1/10) to BEC of Le
negative, non-secretor or secretor donors.
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Figure 4.9 Binding indices for anti-Lex and anti-Lea to BEC of non-secretors.
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4.3.7 Adsorption of Lea by BEC of a Lea"b- donor
The flow cytometry assay (section 3.2.3.4) was used to detect anti-Lea bound to cells
treated with saliva from Lea+^- and Lea~b~ donors.
Adding saliva of a non-secretor (Lea+b~) to BEC of a Le-negative individual (Lea~b-)
increased the binding index of anti-Lea and the increase was dose dependent Table 4.2.
Table 4.3 shows the effect of adding saliva from 7 non-secretors and saliva from a Lea~
donor to BEC of a Lea"^" individual. Generally adding saliva from non-secretors
increased the binding indices; however, there were variation in the values obtained by
using saliva of different individuals. ELISA technique have shown non-secretors
expressed high levels of Lea; however, this variation in the uptake of Lea could be due
to the variation in the avialability of free Lea molecules in the saliva of different
individuals. Adding saliva from a Lea~"~ individual increased the binding index much
less than saliva from the non-secretors.
The effect of adding saliva of a non-secretor to BEC of a non-secretor was much less
compared with its effect on BEC of a Le-negative individual, while adding saliva from
a Lea"b~ individual to BEC from either donor resulted in a much smaller increase
(Table 4.4). Both the percentage and the mean for Lea~b~ was low as compared to
those for Lea+^~. The main difference was in the mean. The mean value for Lea+^~
was 7 times more than that for Lea~k- By adding Lea~^~ saliva to homologous cells
tha mean did not change. In contrast, adding saliva from Lea+^~ to Lea"~b~ cells the
mean increased 17 times.
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Table 4.2 Binding of anti-Lea to cells from a Lewis negative donor treated














Table 4.3 Binding of anti-Lea to cells from a Lewis negative donor treated with























Table 4.4 Binding of anti-Lea to cells from Lea"'3" or a non-secretor donor
treated with PBS, saliva from a Lea"b_ or a Lea+b" donor.
Cells Treatment
Lea-b- + PBS
Lea"b- cells + Lea~b~ saliva
Lea-b- cells + Lea+b~ saliva
Lea+b" cells + PBS
Lea+b- ceus + Lea~b~ saliva
Lea+b- cei]s + Lea+b- saliva








4.3.8 Inhibition of bacterial binding
Binding of S. aureus NCTC 10655 to BEC obtained from 7 secretors and 7 non-
secretors treated with anti-Lea antibody was significantly lower compared with binding
of the bacteria to untreated cells from the same donors (t = 4.46, d.f. = 13, P < 0.001,
95 % CI 55-81) (Fig 4.10). The inhibition was not 100% which implies that there are
other receptors involved in the binding. A similar pattern was observed for binding of
NCTC 10655 to cells of 7 non-secretors and 10 secretors treated with monoclonal
anti-precursor type 1 compared with untreated cells (t = 8.19, d.f. = 16, P < 0.001, 95
% CI 58-72) (Fig 4.11). Binding of this strain to BEC was significantly reduced when
the cells from 6 non-secretor donors were treated with anti-Fex compared with binding
of untreated cells (Fig 4.12).
Although there was no difference in binding of NCTC 8532 to BEC of non-secretors
compared to secretors, binding of NCTC 8532 to the cells from 7 non-secretor and 6
secretor donors treated with anti-Eea antibody was significantly lower compared with
binding of the bacteria to untreated cells (t = -4.97, d.f. = 11, p < 0.001, 95 % CI 43-
72) Fig (4.13). This implies that the difference in bacterial binding is more likely to the
difference in the expression of antigens on the BEC. Inhibition of NCTC 8532 with







Figure 4.10 Effect of incubation of anti-Lewisa with BEC from non-secretor (NS)
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Figure 4.11 Effect of incubation of anti-precursor type 1 with BEC from NS and
S donors on binding of S. aureus NCTC 10655.
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Donors
Figure 4.12 The effect of incubation of anti-Lewisx with BEC from 6 donors on








Figure 4.13 Effect of incubation of anti-Lewis3 with BEC from NS and S donors
on binding of S. aureus NCTC 8532.
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4.3.9 Binding of bacteria with reference to detection of Lea
antigen, precursor antigen or Lex
Binding of S. aureus NCTC 10655 correlated with the amount of anti-Lea antibody
detected on the BEC of 8 secretors and 7 non-secretors (t = 5.03, d.f. = 12, P <0.001)
(Table 4.5). A similar pattern was found with NCTC 8532 (/ = 4.24, d.f. = 12, P
<0.001) (Table 4.6). There was no significant correlation between the amount of anti-
precursor type 1 detected on BEC and binding of NCTC 10655 or NCTC 8532 (Table
4.7). There was no correlation between the amount of Lex detected on BEC and
binding of NCTC 10655 (Table 4.8).
4.4 Discussion
The objectives of this chapter were to assess the level of expression of Lea on BEC of
secretors and non-secretors and to determine if the S. aureus strains examined in the
binding assays have adhesins that recognise Lea.
ELISA readings in the assay for Lea with saliva of non-secretors were 4-5 times
greater than those for secretors, but there was considerable variability in the OD
readings among the secretors. There were generally low values for Let* among the
non-secretors. The OD readings for Le^ were variable with the saliva of secretors.
Very low readings for both Lea and Le^ were obtained with saliva from donors whose
erythrocytes were not agglutinated by anti-Lea or anti-Le^. These results gave
expected values as non-secretors will form mainly Lea from precursor type 1 and Le*3
can not be formed in their secretions.
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Table 4.5 Correlation between binding of anti-Lea and binding of S. aureus
NCTC 10655 to cells of secretors and non-secretor donors.
Donors Anti-Lea (BI) NCTC 10655 fBD
















Table 4.6 Correlation of binding of anti-Lea and binding of S. aureus NCTC
8532 to cells of secretors and non-secretor donors.
Donors Anti-Lea(BI) NCTC 8532(BI)
















Table 4.7 Correlation of binding of anti-precursor type 1 and binding of 5.

































Table 4.8 Correlation of binding of anti-Lex to binding of S. aureus NCTC 10655
to BEC of non-secretor donors.
(Ml








By flow cytometry, BEC from non-secretors generally bound more anti-Lea than those
from secretors. Secretors bound highly variable amounts of anti-Lea. BEC from
donors who were Lea~'3~ by haemagglutination had low BI for anti-Lea. This could be
due to anti-Lea cross-reacting with precursor type 1 [Good et al., 1992] or these
individuals had low levels of Lea not detectable by haemagglutination. The BI for anti-
Le'3 bound to BEC for the secretors were higher than those for non-secretors. The
values of anti-Lc'3 for the non-secretors indicate that anti-Le'3 might be cross reactive
with Lea as non-secretors do not express Le^ in their saliva or on their BEC. Anti-Le^
was not included in further experiments for flow cytometry.
The results obtained with flow cytometry agreed with those obtained by
haemagglutination and ELISA methods. Individuals whose erythrocytes were
agglutinated strongly by anti-Lea had high OD for anti-Lea with their saliva in the
ELISA and high BI for anti-Lea bound to their BEC measured by flow cytometry.
Individuals whose erythrocytes were agglutinated by anti-Le'3 had variable amounts of
Lea in their saliva and on their BEC.
There was less cross-reactivity with anti-Le'3 in the ELISA than in the flow cytometry
studies. The cross reactivity of anti-Le'3 was also pointed out by other workers [Good
etal., 1992],
Precursor type 1 was not detected on BEC of every donor and binding of the antibody
did not correlate with the secretor status of the donors or the BI for anti-Lea. This
structure was predicted to be the main epitope of Lewis negative ABH non-secretor
individuals [Le Pendu, 1982], There was no Lewis negative ABH non-secretor
individual among the donors tested for the study.
Anti-Lex bound to BEC from Lea+ and Lea"'3" donors. It is most likely that the gene
for Lex is different from that for Lea as BI values for both antibodies did not correlate.
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The Lex antigen (CD 15) results from the transfer of the a 1-3 fucose residue to the P
GlcNAc of the type 2 precursor chain (Oriol et al., 1986). This antigen is also widely
distributed in several cell types and secretions (Gooi et al., 1993).
BEC from Le^b- donors absorbed large amounts of molecules containing Lea
determinants when they were incubated with non-secretor saliva. This is in agreement
with other studies on absorption of Le antigens from plasma by Lea~b~ red blood cells
(Marcus and Cass, 1969). BEC from non-secretors absorbed less Lea from non-
secretor saliva than the Le3""'3- cells. This indicates that the Lea was near saturation
levels on the BEC of non-secretors and this made it difficult to adsorb more molecules
as compared with BEC of Lewis negative donors. Some sort of exchange might also
occur especially in the cells with precursor typel. There was much less enhancement of
BI for cells from either the Lea"b" donor or non-secretor donor incubated with saliva
from Lea_b" and these results support what is expected as saliva from Lea"b" donors
do not express Lea inorder to be uptaken by the cells; incontrast, they might add some
precursor type 1 molecules to the cells.
Attachment of strain NCTC 10655 which bound in greater numbers to non-secretor
cells was significantly inhibited by treatment of the host cells with monoclonal anti-Lea
antibody, monoclonal anti-precursor type-1 and anti-Lex antibody. Anti-precursor
type-1 antibody was examined because it has been suggested that bacteria might bind
to the precursor portion of the ABO or Lewis blood group antigens; and glycosylation
of the precursor to H or Lewis antigens decreased the accessibility of the binding site
(Rosenstein et al., 1988). Anti-Lex antibody was included in the study as Lex is the
type 2 isomer of Lea. Both Lea and Lex are oligosaccharides having the same sugar
composition but differ steriochemically.
There was a significant correlation between binding of NCTC 10655 and binding of
anti-Lea antibody to the host cell (Table 4.4), but there was no correlation between
113
binding of this strain with the amount of either anti-precursor or anti-Lex antibodies
detected on the cells. As the anti-precursor monoclonal was prepared by immunisation
with Lea antigen, the inhibition of bacterial binding observed following pre-treatment
of cells with anti-precursor might be due to cross-reactivity with Lea although none
was indicated by the manufacturer. The inhibition of bacterial binding following pre-
treatment of cells with anti-Lex might be due to the adhesins recognising a
carbohydrate domain common to both Lea and Lex antigens.
Although NCTC 8532 did not bind in greater numbers to non-secretor cells compared
with secretor cells (Fig 3.10), its binding was inhibited by treatment of the epithelial
cells with anti-Lea (Fig 4.13) and there was a significant correlation between its
binding to the donor cells and the amount of anti-Lea antibody bound by the cells.
Some secretors bind as much anti-Lea as most non-secretors. For the experiments
comparing the binding of staphylococci to cells from secretors and non-secretors, the
donors were matched only according to, sex, age and ABO blood group; and the same
pairs of secretor / non-secretor donor were not available for each experiment. At that
time there was no information on the amount of anti-Lea bound by the cells of
individual donors.
Further evidence that both NCTC 10655 and NCTC 8532 have adhesins that bind Lea
was obtained with co-agglutination studies using anti-idiotyplc antibodies produced
against monoclonal anti-Lea, the Fab portions of which resemble the epitope bound by
the monoclonal anti-Lea. All the staphylococcal strains tested were agglutinated :
NCTC 8532, NCTC 10652, NCTC 10654, NCTC 10655, NCTC 11965 and 41206
[Essery et al., 1994b],
The results of this chapter indicate that:
1. The adhesin that bind Lea is present on all strains tested.
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2. Binding of NCTC 10655 and NCTC 8532 was correlated with the binding of anti-
Lea.
3. Differences in binding of staphylococcal strains observed in chapter 3 are not due to
absence of adhesins that bind anti-Lea.
4. Expression of Lea represented in binding of anti-Lea on secretors is highly variable.




Isolation of an adhesin from Staphylococcus
aureus that binds Lewisa blood group antigen
5.1 Introduction
Epidemiological studies have found that individuals who are non-secretors of the ABO
blood group antigens are over-represented among patients with some bacterial diseases
and among carriers of some potentially pathogenic bacteria. The Lea antigen, present in
greater quantities on epithelial cells of non-secretors, might be a receptor for some
adhesins on strains of these bacterial pathogens. If so, individuals who express significant
amounts of Lea might be more readily or more densely colonized by these organisms
[Blackwell, 1989b],
The results in chapter 4 indicated that binding of both toxigenic and non-toxigenic strains
of S. aureus to epithelial cells was correlated with the amount of Lea antigen detected on
the cells; and, monoclonal antibody to this antigen can block attachment of these bacteria.
These results suggest that some surface-exposed proteins on S. aureus strains might be
adhesins that use Lea as a receptor.
Adhesion of staphylococci to various tissues involves non-specific, hydrophobic
interactions, as well as biospecific interaction, via binding proteins [Vercellotti et al.,
1984]. S. aureus has a large number of agglutinogens; however, identification of specific
adhesins that mediate binding to eukaryotic cells is limited. In this chapter an attempt was
made to isolate the surface component of S. aureus that binds Lea antigen and to use it to
reduce attachment of the bacteria to epithelial cells.
116
5.2 Materials and methods
5.2.1 Bacterial strains
Lyophilised S. aureus strains NCTC 10655, NCTC 10652 and NCTC 8532 were cultured
on nutrient agar for 24 h at 37°C. For each strain, growth from 20 plates was collected;
this yielded (2g) of bacterial pellet.
5.2.2 Cell wall isolation
A modification of methods described previously [Cheung et al., 1988; Sharp and Poxton,
1988] was used. Bacteria were suspended in washing buffer (0.05M Tris HC1, 0.025M
MgCl2 and 0.15M NaCl, pH 7.6) and centrifuged for 20 min at 2000 g at 4°C. The
bacterial pellet (2g) was suspended in 15 ml of freshly prepared washing buffer containing
DNAse-1 (50 ug) (BDH, 39012) and RNAse (50 ug), (Calbiochem, lot 902237). The pre-
cooled (4°C) cell suspension was passed twice through a French Pressure Cell (American
Instrument Co., Silver Spring, Md. USA) pa = 6000-7000 lb/in^ then centrifuged at 2000
g for 20 min at 4°C to remove intact bacteria. The supernatant was then centrifuged at
20,000 g for 30 min to recover the cell wall material. The resulting pellet was washed 3
times in ice cold distilled water by centrifugation at 30,000 g for 15 min at 4°C.
5.2.3 Extraction of cell wall protein
The pellet from the crude cell wall preparation was resuspended at room temperature in 5
ml of 2% (v/v) Triton X-100 (Sigma T-6878) in water for 30 min and centrifuged at
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20,000 g for 20 min. After two such extractions, the pellet was dissolved in 5 ml of a
freshly prepared solution containing 50 (ig/ml lysostaphin (Sigma L-7386) in 0.05 M
Tris/HCl with 0.145 M NaCl (pH 7.6) and incubated at 37°C for 2h with continuous
shaking. After centrifugation at 45,000 g for 20 min at 4°C, the supernatant was freeze
dried, reconstituted in distilled water and stored at -20°C.
5.2.4 Purification of adhesins by affinity adsorption
Synsorb affinity adsorbent (100 mg) (ChemBiomed Ltd., Edmonton, Alberta, Canada; lot
Asi-137) with Lea covalently linked to the silica matrix was swollen in a Falcon tube in 2
ml of PBS (pH 7.2) for 2 h at RT with continuous rotation. The beads were centrifuged at
50 g for 5 min and the supernatant removed. The protein extract (0.17 mg in 1 ml) from
strain NCTC 10655 was added to the beads, rotated overnight at 4°C and centrifuged at
50 g for 5 min. The supernatant containing unbound material was collected. The beads
were washed twice with 2 ml of PBS and the washings added to the unbound material.
The bound material was eluted from the beads with 1 ml of 2% ammonia in saline for 20
min with continuous rotation at room temperature. The supernatant was recovered
following centrifugation at 50 g for 5 min. The beads were finally washed with 2 ml of
PBS and the eluate added to the previous supernatant. The original sample and all extracts
were freeze dried, reconstituted in distilled water and dialysed overnight against Tris / HC1
(0.01 M, pH 7.4) at 4°C.
118
5.2.5 Polyacrylamide gel electrophoresis (PAGE)
The buffer system of Laemmli [1970] with 10% acrylamide in a Biometra-Minigel
(Biometra, Wagen-Stieg, Gottingen, Germany) was used. Protein content was determined
by the method of Bradford [1976] using Coomassie brilliant blue with bovin serum
albumin as standard. Samples (20 |il) containing 8 jag protein were applied to each lane of
the gel for 1-2 h, at 60 volts for the stacking gel (5% acrylamide) and 150 volts through
the resolving gel (10% acrylamide) to complete the run and stained with Coomassie blue.
Molecular weight markers (Sigma) in the range of 29-205 kDa were run in parallel.
5.2.6 Inhibition assay
The affinity purified extract and the unbound material of NCTC 10655 prepared as above
(5.2.4) were made up to a protein concentration of 15 [tg/ml. A volume (100 (il) of each
was added to 100 [il suspensions of BEC (2.5 x 10~Vml) taken from 3 healthy individuals
expressing Lea. BEC incubated with 100 [tl of PBS were included as untreated controls.
After incubation for 1 h at room temperature, the cells were washed twice with PBS by
centrifugation at 300 g for 10 min. S. aureus NCTC 10655 (100 jlxI) labelled with FITC by
the method described in chapter 3 were added to the BEC at a ratio of 640 bacteria/cell.
After 30 min at 37°C with continuous shaking, the cells were washed twice with PBS,
fixed with 1 % paraformaldehyde and analysed by flow cytometry as previously described
in Chapter 3. The binding index (BI) for each sample was calculated by multiplying the
percentage of fluorescent cells by the mean fluorescence channel of the positive
population. The percent inhibition was calculated by the formula:
100 - [(BI test / BI control) x 100].
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5.3 Results
5.3.1 Cell wall preparation
The protein profiles by PAGE of the material solubilised by lysostaphin from strains
NCTC 10655, NCTC 10652 and NCTC 8532 are shown in Fig 5.1. The band at 28 kDa is
the lysostaphin. All three strains gave almost identical patterns.
Fig 5.2 shows the peptide bands of strain NCTC 10655 before and after adsorption with
Synsorb Le . The bands for the unbound material (track 2) and the original cell wall
material (track 1) show similar patterns of multiple bands while the eluate (track 3) has a
major band of approximately 67 kDa. The protein concentration of the original cell wall
extract was 170 |ig/ml and that of the unbound material and Synsorb eluate were 150 (ig
/ml and 15 fig/ml respectively.
5.3.2 Inhibition studies
The ability of the protein preparations to inhibit binding of S. aureus NCTC 10655 to
BEC was assessed by flow cytometry. Three experiments were performed. In each
experiment, the percentage inhibition was greater for the protein eluted from Synsorb Lea
(Table 5.1). The eluate from a control preparation obtained by passing lysostaphin
solution through the Synsorb beads showed no inhibition of bacterial binding to buccal
epithelial cells (data not shown).
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Fig 5.1 Coomassie brilliant blue-stained SDS-PAGE (10%) of proteins (8 jig)
extracted from S. aureus NCTC 10655 (lane 1), NCTC 10652 (lane 2), NCTC 8532
(lane 3).
121





Fig 5.2 Commassie brilliant blue-stained SDS-Page (10%) of cell wall extracts of S.
aureus NCTC 10655 (lane 1), unbound material (lane 2), and Synsorb-Lewisa eluate
(lane 3).
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Table 5.1 Inhibition of binding of S. aureus NCTC 10655 by pre-treatment of BEC
with protein preparation (15 (Xg/ml) eluted from Synsorb-Lea or the unbound
material.
% inhibition
Experiment Whole extract Unbound protein Svnsorb-Le^ eluate
1 44.8 25.5 54.8
2 ND* 6.5 24
3 ND* 13.3 25.7
(*ND = not done).
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5.4 Discussion
The Synsorb-Lea affinity purification isolated a major polypeptide of 67 kDa from outer
membranes of S. aureus. The cell wall preparations were capable of inhibiting attachment
of strain NCTC 10655 to buccal epithelial cells; the inhibitory activity of the eluate from
Synsorb Lea was greater than that of the unbound material. This supports the results in
chapter 4 which found that binding of S. aureus strains to BEC was significantly
correlated with the amount of Lea on the cells and binding of both NCTC 10655 and
NCTC 8532 to these cells could be significantly reduced by pre-incubation of the cells
with monoclonal anti-Lea .
Complete inhibition of binding was not predicted because there are many receptors for S.
aureus on epithelial cells [Sandford, 1986], S. aureus cell wall components, lipoteichoic
acid [Carruthers and Kabat, 1983], teichoic acids [Aly et al., 1980] and protein A [Cole
and Silverberg, 1986; Wyatt, 1990] have been implicated in adherence.
Relatively little is known about cell-wall proteins of S. aureus other than protein A.
Another cell wall protein previously identified is a fibronectin-binding protein of 210 kDa
[Ciborowski et al., 1992], The fibronectin receptor is expressed in greater quantities on
invasive S. aureus isolates than non-invasive isolates; and it has been implicated in
adherence of S. aureus to squamous epithelium [Aly, 1987]. Fibronectin binding is not
regarded as an important mechanism of adhesion to a host tissue where a large number of
both protein and carbohydrate components could conceivably be recognised by microbial
adhesins. The molecular mass of the Lea adhesin 67 kDa differs from those reported for
adhesins binding fibrinogen (19 kDa, 60 kDa and 87 kDa) [Boden and Flock, 1992] or
fibronectin (210 kDa) [Ciborowski et al., 1992],
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Surface protein antigens are probably important in eliciting host immune responses to S.
aureus infection [Cheung, 1988]. The adhesin isolated from this study could be useful in
defining markers of epidemiological importance and antibodies to this adhesin in




The role ofBordetella pertussis in SIDS
6.1 Introduction
B. pertussis colonises the respiratory tract and causes infant death from whooping cough
(pertussis). It has been suggested that some cases of SIDS are due to asymptomatic
infection with B. pertussis [Nichol and Gardner, 1988], or alternatively, caused by
immunization for diphtheria, pertussis and tetanus (DPT) [Torch, 1982 and Baraff et al.,
1983]. Epidemiological studies did not confirm the hypothesis regarding immunization; the
data indicated that the unimmunised infants were at greater risk of SIDS [Emery, 1981;
Hoffman et al., 1987 and Walker et al., 1987].
There is no evidence of systematic surveys for these bacteria in SIDS infants; and the
bacteria are difficult to culture even from children with symptomatic whooping cough
[Davis et al., 1990]. Consequently, there are no reports that B. pertussis has been isolated
from SIDS infants.
This micro-organism is well endowed with potential adhesins: filamentous haemagglutinin
(FHA); pertussis toxin (PT); and fimbriae. Both FHA and PT are exposed on the surface
of B. pertussis, but their relative contributions to colonization of epithelial surfaces are not
clear [Tuomanen and Weiss, 1985]. B. pertussis can bind to monocytes through its toxin;
and the toxin has been demonstrated to bind Lea and Lex antigens on these cells [van
t'Wout et al., 1992]; however, there were no reports on the role of these antigens in
colonization of epithelial surfaces by B. pertussis.
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In addition to the campaign to place infants on their backs to sleep, there have been other
changes in infant health care that might have contributed to reduction in SIDS observed in
Scotland since 1990. As well as initiation of immunization for DPT at the earlier age of 2
months, there has been a return of confidence in pertussis immunization reflected in the
steady increase in vaccination uptake from the late 1980's [Preston, 1993], If some cases
of SIDS were due to asymptomatic pertussis, earlier immunization might help prevent a
portion of these death. This might be reflected in a shift in the age distribution of SIDS
cases with an increase in the younger age group.
The aim of this chapter was to test two hypothesis: first that colonization of young infants
by B. pertussis might be enhanced by the bacteria binding to Lea and Lex on epithelial
cells; second, there would be an increase in the proportion of unimmunized infants (< 2
months of age) among SIDS cases following initiation of DPT immunization at 2 months
instead of 3 months.
6.2 Materials and methods
6.2.1 Preparation of bacteria
Two strains of B. pertussis were kindly provided by Dr. N.W. Preston, Department of
Microbiology, Manchester University: 8002 (fimbriate, type 1,2); 250815 (non-fimbriate,
type 1,3). Both strains were grown on charcoal blood agar plates and incubated for 6 days
at 37°C. For storage, colonies were emulsified in Microbank beads and kept at -20°C. A
fresh bead was used to inoculate plates for each set of experiments.
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6.2.2 Total bacterial count
Total numbers of B. pertussis were determined by the optical density method described in
2.8.3.
6.2.3 Binding of bacteria to BEC
Binding of bacteria labelled with FITC to BEC of healthy donors was assessed by the flow
cytometry method as described in 3.2.3.4.
6.2.4 Detection of Lea and Lex on BEC
The flow cytometry method described in chapter 3 was used to detect Lea and Lex
antigens on BEC.
6.2.5 Inhibition of bacterial binding
The method described in 4.2.5 was used in these experiments. BEC were treated with
PBS, monoclonal anti-Lea (1/2) or anti-Lex (1/10). The attachment assay was then
performed with B. pertussis (500 bacteria : cell). The results were analysed by flow
cytometry.
6.2.6 Statistical methods
Statistical analyses were carried out on the logarithms of the binding indices. Differences
between groups were tested by paired or unpaired t-tests as appropriate, and confidence
limits for the mean values in one group were expressed as percentage of those in the other
by taking antilogarithms.
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Statistics on the number of cases of SIDS was obtained from the Scottish Cot Death Trust
national survey. Ages of SIDS cases in the Lothian, Borders and Fife area from 1988 to
1992 were obtained from autopsy reports. The change in the proportion of cases < 2
months of age over time was tested using a chi-squared test for trend.
6.3 Results
6.3.1 Correlation of total bacterial count with OD
The linear correlation between readings of OD with total bacterial count for both strains of
B. pertussis tested is shown in Figure 6.1.
6.3.2 Optimal time for bacterial binding
At a concentrations of 500 bacteria / cell of FITC-labelled B. pertussis were incubated
with BEC at 45, 120 and 180 min. Attachment was adequate at 120 min (Figure 6.2) and
further binding assays were performed at this incubation time.
6.3.3 Bacterial binding dose response
Binding of B. pertussis strain 8002 and strain 250815 to BEC were performed with five
different ratios of bacteria per cell : 63, 125, 250, 500 or 1000 : 1. Figure 6.3 shows the
dose response effect. Bacterial binding was sufficient at 500 bacteria per cell and this ratio
was used for further experiments.
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Figure 6.1 Total bacterial count (number X 10"^) per ml determined by
microscopy versus optical density of B. pertussis strains 8002 and 250815.
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Figure 6.3 Dose response for B. pertussis strain 8002 and strain 250815
binding to EEC.
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6.3.4 Inhibition of bacterial binding
Figure 6.4 compares binding of B. pertussis strain 8002 to epithelial cells treated with
PBS, anti-Lea or anti-Lex. Binding of 8002 to cells treated with anti-Lea was significantly
lower compared with the control treated with PBS (t = - 2.93, CI 86-99%, p < 0.05).
Pretreatment of cells with anti-Lex also significantly reduced binding of 8002 (t = - 4.32,
CI 45-82%, p < 0.01). Although there appeared to be less Lex antigen present on the
cells, inhibition of bacterial binding was greater if the cells were pre-treated with anti-Lex
than with Lea (P < 0.01, 95% CI 51-84%). Similar results were obtained with strain
250815 (Figure 6.5). Bacterial binding to cells treated with anti-Lea was significantly
lower than the control (PBS). There was significant inhibition of binding with anti-Lea (t =
-3.23, CI 71-94%, P < 0.05) or with anti-Lex (r = -4.41, CI 64-86, P < 0.01).
6.3.5 Age distribution of SIDS cases in Scotland
Although the number of SIDS cases in Scotland has decreased since 1990 (Figure 6.6),
the proportion of infants in Lothian, Borders and Fife aged 2 months or less has increased
from 16% in 1988 to 40% in 1992 (X2 = 5.53, P = 0.02) (Table 6.1).
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Figure 6.4 Inhibition of binding of B. pertussis strain 8002 by pre-treatment of BEC
with monoclonal anti-Lea or anti-Lex.
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Figure 6.5 Inhibition of binding of B. pertussis strain 250815 by pre-treatment of
BEC with monoclonal anti-Lea and anti-Lex.
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Figure 6.6 Cases of SIDS in Scotland 1980-1992
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Table 6.1 Age distribution of SIDS cases in Lothian, Borders and Fife regions 1988-
1992
Year Total </2 months >2 months
(no%)
1988 25 4 (16) 22(88)
1989 26 3 (11.5) 23 (88.5)
1990 31 9(29) 22(71)
1991 13 4(31) 9(69)
1992 10 4(40) 6(60)
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6.4 Discussion
The results of chapter 3 and 4 identified factors which might enhance colonization of
infants by toxigenic staphylococci during the 2-4 month age range in which most SIDS
cases occur. A similar pattern was found in this study with B. pertussis. Binding of both
strains of B. pertussis tested was significantly inhibited by pre-treatment of epithelial cells
with either anti-Lea or anti-Lex The pattern of inhibition was similar for both the strains
tested.
As there is little maternal antibody against pertussis, young infants are very vulnerable to
these bacteria. A proportion of SIDS in the unimmunized age range might be due to
asymptomatic pertussis. Infants less than 6 months of age do not develop the typical
paroxysms and the infection might not be diagnosed since the organisms are difficult to
culture even from symptomatic patients. The cause of death in these infants could be
hypoglycaemia. The predominant effect of pertussis toxin is stimulation of insulin from the
pancreas [Davis et al., 1990] and TNF a produced in response to pertussis can also cause
hypoglycaemia. In a Finnish study, two-third of the 57 SIDS infants were younger than 3
months; about half had a mild "virus-like" infection approximately one week before death
and serum insulin levels were significantly lower for the SIDS infants compared with those
who had died of other causes. Hyperplasia of the islet cells was observed in the SIDS
infants [Hirvonen et al., 1980].
The antibodies induced by the whole cells and the toxoid contained in the pertussis vaccine
might also be cross reactive with shared epitopes on adhesins and toxins of other species.
These crossreactive antibodies might contribute to decreased colonization by toxigenic
bacteria or partially neutralise the effects of their toxins. The pertussis toxin acts as an
adhesin and binds to Lea and Lex on human monocytes [van t'Wout et al., 1992], the
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finding that the staphylococcal enterotoxin B binds to Lea and Lex [Essery et al., 1994a]
is further evidence for this hypotheses; and immunological cross-reactivities between
antibodies to staphylococcal pyrogenic toxins, pertussis toxin and whole cells of B.
pertussis have been demonstrated by ELISA [Essery et al., 1994c],
The increased uptake of pertussis vaccine during the past few years [Preston, 1993] and
the change in immunization schedule might contribute in two ways to the observed
decrease in SIDS noted since 1990. First, immunization would reduce those cases of SIDS
suggested to be due to asymptomatic pertussis [Nichol and Gardner, 1988], Studies with
the ferret model found that viral infection greatly enhanced the effect of diphtheria toxin, if
there is a parallel in human infants, DPT immunization might also reduce the risk of death
due to these bacteria. Second, if immunization with pertussis toxoid produces antibodies
cross-reactive with epitopes on adhesins or toxins of other bacterial species that bind Lea
and / or Lex, this will induce immunity to pertussis and might also reduce the effects of
toxigenic strains of staphylococci.
More detailed epidemiological studies of SIDS before and after October 1990 are needed
to obtain additional evidence to support or refute this hypothesis. Studies to detect the
presence of pertussis in the oropharynx of infants have been initiated and methods to
detect the pertussis toxin in tissues are under development.
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Chapter 7
Viral infections as predisposing factors for
colonization by bacteria and their association
with SIDS
7.1 Introduction
Although there is no direct evidence for viruses causing cot death [Fleming, 1992], they
might be predisposing factors for colonization by toxigenic bacteria or exacerbate the
effect of bacterial colonization [Jakeman et al., 1991]. Much of the work on enhancement
of bacterial colonization has been done on influenza virus and superinfection by
staphylococci or pneumococci [Plotkowski et al., 1984]. The involvement of viruses rests
on clinical experience, epidemiological studies and from laboratory evidence that virus
infection predispose people to some bacterial diseases by enhancing colonization by
pathogenic bacteria [Ramirez-Ronda et al., 1981 and McDonald et al., 1987].
Respiratory syncitial virus (RSV) was taken as a model for this study because it is an
important, ubiquitous respiratory pathogen causing infection in young infants during the
winter months when SIDS is most common [Noah et al., 1989]. In addition, this virus has
been identified in SIDS infants [Ogra et al., 1975; Williams et al., 1984] and Ford et al.,
[1990] reported a weak association with SIDS in a New Zealand study. Finally, cells
infected with RSV have been shown to bind significantly more Neisseria meningitidis and
type b Haemophilus influenza than uninfected cells [Raza et al., 1993].
In this part of the study an attempt was made to determine if tissue culture cells infected
with RSV bind greater numbers of S. aureus or B. pertussis than uninfected cells.
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7.2 Materials and methods
7.2.1 Bacteria
Two strains of S. aureus, NCTC 10655 and NCTC 8532 and two strains of B. pertussis, a
fimbriate strain 8002 and a non-fimbriate strain 250815, were used. The strains of S.
aureus were grown on nutrient agar and fresh subcultures from an overnight growth at
37°C were used for each experiment. The strains of B. pertussis were grown on charcoal
blood agar for 6 days at 37°C and a total bacterial count for each strain of both bacteria
was performed by microscopy as described in 2.8.3.
7.2.2 Cells
HEp-2 cells (Flow laboratories) were used for the binding assays. Cell growth medium
consisted of Eagle's minimal essential medium (Gibco) supplemented with 10% foetal calf
serum (Gibco), NaHCC>3 (0.85 g/1), L-glutamine (2 mM), streptomycin (200 (tg/ml) and
penicillin (100 IU/ml). Maintenance medium contained all the constituents of cell growth
medium but only 1 % foetal calf serum. The cells used in the bacterial binding studies were
suspended by applying 1 ml EDTA (0.05%) to monolayers in 25 cm^ flask for 10 min at
37°C after the cells were suspended in growth medium or in maintenance medium.
7.2.3 Virus and virus infected cells
Both the RSV infected and the uninfected HEp-2 cells were provided by Dr. M. W Raza,
Department of Medical Microbiology.
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One day old monolayer of HEp-2 cells in culture flasks (25 cm^) were infected with RSV
(1 ml in maintenance medium) (Edinburgh strain) [Ogilvie et al., 1981] at multiplicity of
infection of 2-3 infectious particles per cell for 60 min. The medium was replaced and
incubated with 10 ml maintenance medium overnight at 37°C.
Cultures were rinsed with PBS and 1 ml per flask of ethylenediaminetetraacetic acid
(EDTA) (0.05%) was added at 37°C for 10 min. Maintenance medium (5) ml was added
to counteract the effect of EDTA. The suspension was centrifuged at 700 g for 10 min and
the cells were resuspended in maintenance medium. The cell count was adjusted to 10^
cells/ml using a Neubauer haemocytometer.
7.2.4 Bacterial binding to HEp-2 cells in suspension
The bacterial suspension was labelled with FITC and the binding assays were performed as
described in chapter 3. For S. aureus, the attachment of bacteria to RSV-infected HEp-2
cells and uninfected cells was determined using 160 bacteria : cell, 320 bacteria : cell and
640 bacteria : cell at two incubation periods, 30 and 120 min. For B. pertussis ratios of
bacteriaxell ranging from 400-6400 were tested at an incubation time of 120 min. The
proportion of RSV-infected cells was determined by flow cytometry [Raza et al., 1993].
Mouse monoclonal antibody to RSV-F protein was reacted with RSV-infected cells. The
cells were washed and 20 p,l of FITC-labelled anti-mouse IgG antibody (Sigma) was
added and incubated for 30 min at 37°C. The rest of experiment was carried out as
described in 4.2.3.
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7.2.5 Analysis of binding by flow cytometry
Each sample was analysed by flow cytometry as described above (3.2.3.4).
Immunoanalysis was used in the analysis and the binding index (BI) of each sample was
determined.
7.2.6 Statistical methods
The analyses were carried out on the logarithms of the binding indices and a three-factor
analysis of variance was used to test whether RSV infection was related to bacterial
binding to HEp-2 cells at two different concentrations of bacteria per cell.
7.3 Results
7.3.1 Binding of bacteria to RSV infected HEp-2 cell
The percentage of RSV-infected cells was determined at the time of the attachment assay
by flow cytometry. The proportion of cells binding the specific anti-F antibody was > 80%
for each experiment.
7.3.1.1 Dose response
The effect of RSV infection on the attachment of S. aureus strain NCTC 10655 to HEP-2
cells is shown in (Figure 7.1). The infected cells bound more staphylococci than the
uninfected cells at both concentrations of bacteria used (320 and 640 bacteria/cell) and it


















































The attachment of S. aureus strain NCTC 10655 to HEp-2 cells was measured using 320
and 640 bacteria / cell at two incubation periods (30 min and 120 min) (Figure 7.3).
Binding increases over 120 min, but the incubation at 30 min gave a reasonable attachment
and this incubation time was used for the further experiments. The incubation time for
attachment of B. pertussis was carried out at 120 min. as it was the optimal time for the
binding with the epithelial cells in a previous study (6.3.2).
7.3.1.3 Effect of RSV infection
Statistics were performed on the results of seven experiments on binding of S. aureus
strain NCTC 10655 to RSV infected HEp-2 cells compared with binding to uninfected
cells. The binding indices for the RSV-infected cells were greater than for the uninfected
cells : P < 0.05, 95% CI 109-155%, after adjusting for the effect of bacterial concentration
on binding (Figure 7.4).
The binding indices for B. pertussis strain 8002 to RSV infected cells were greater than
for the uninfected cells for all the ratios of bacteria per cell used (Figure 7.5), and strain
250815 gave a similar pattern (Figure 7.6). For each strain there was a similar pattern for




Figure 7.3 Binding of S. aureus strain 10655 to HEp-2 cells and HEp-2 cells infected


















Figure 7.4 Binding of S. aureus strain NCTC 10655 to HEp-2 cells and HEp-2 cells















Figure 7.6 Binding of B. pertussis strain (250815) to HEp-2 ceils or RSV infected
HEp-2 cells with different ratios of bacteria / cell.
150
7.4 Discussion
For many years it has been recognised that viral infection might increase susceptibility to
secondary bacterial infection [ Nichol and Cherry 1967]. Viral infections have been shown
to enhance carriage of staphylococci [Ramirez-Ronda et al., 1981] and toxic shock
syndrome caused by toxin producing staphylococci has been identified as a complication
of influenza or influenza like-illness. [McDonald et al., 1987]. Binding of both
meningococci and type b Haemophilus influenzae to tissue culture cells derived from
human epithelium (HEp-2) was significantly increased when the cells were infected with
RSV [Raza et al., 1993]; and, in this study, both the toxigenic strain of S. aureus and the
two strains of B. pertussis tested bound in greater numbers to the RSV-infected cells. If
there are similar interactions in vivo infection with RSV, common during the first year of
life, might also enhance colonization by these bacteria.
Two hypothesis have been proposed to explain why virus infected cells bind more
bacteria: virus infection upregulates expression of host cell surface antigens that can act as
receptors for bacteria; new antigens coded for by RSV expressed on the surface of
infected host cells can act as additional receptors for bacteria [e.g, the F (fusion) and G
(adhesion) glycoproteins]. There is evidence to suggest both hypotheses.
Viral infections induce y-interferon which enhances expression of CD 14 to which bacterial
endotoxins bind. RSV-infected HEp-2 cells bind more monoclonal antibody to CD 14 than
the uninfected cells (Raza et al., 1994). The expression of CD 14 and binding of endotoxin
to cultured monocytes was enhanced by pretreatment of the cells with interferon [Jackson
et al., 1993]. This might be one of the explanations for the enhanced binding of the B.
pertussis to the RSV infected cells as these bacteria produce endotoxin. RSV infection
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also enhanced expression of Lex on HEp-2 cells and anti-Lex significantly inhibited the
binding of S. aureus and B. pertussis to epithelial cells.
There is evidence that glycoprotein G (but not glycoprotein F) of RSV acts as an
additional receptor for meningococci. Future work with this model will explain the roles of




The aims of this chapter are to examine the results obtained in the previous chapters in the
context of the original objectives of the project; to highlight the applications or limitations
of the experiments and methods of analysis used throughout this study; and to suggest
future work.
8.1 Objectives of the project
The results of this thesis provided answers for the questions to be investigated. The first
objective was to test the hypothesis that Lea antigen is a receptor on epithelial cells for
toxigenic bacteria such as S. aureus and B. pertussis. As secretors were suggested to have
lower levels of Lea on their cells compared with non-secretors, binding of staphylococci to
cells from secretor and non-secretor donors was examined. There was not a clear
difference in binding of all strains of staphylococci to cells of secretors and non-secretors.
Assessment of binding of anti-Lea to BEC of donors helped resolve these observations.
The amount of Lea on the cells of secretors was highly variable, some bind as much anti-
Lea as cells of non-secretors (Figure 3.3). Inhibition of binding by pretreatment of BEC
with anti-Lea and correlation between bacterial binding and amount of anti-Lea bound to
cells provided additional evidence that Lea could be a receptor for S. aureus. Subsequent
isolation of the bacterial cell wall adhesin by Synsorb-Lea and complementary studies in
which anti-idiotypic antibodies to monoclonal anti-Lea were found to agglutinate all
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staphylococcal strains tested were further evidence for the hypothesis [Essery et al.,
1994b],
The second objective was to test the effect of RSV infection on binding to epithelial cells.
Binding of both S. aureus and B. pertussis was greater for RSV infected cells. While virus
infection might not be a direct cause of SIDS, it might contribute to colonization by
potentially pathogenic bacteria.
8.2 Applications and limitations ofmethods and results
8.2.1 Assessment of bacterial binding by flow cytometry
One of the advantages of flow cytometry is the ability to analyse large numbers of cells in
a short time. Direct labelling of bacteria with FITC was used for the study. Some workers
have used fluorescent antibodies to identify attached or suspended bacteria [Donnelly and
Baiegant, 1986]; however such an approach might alter the viability or receptor properties
of bacteria before exposure to eukaryotic cells. Direct labelling of S. aureus with FITC did
not affect their binding to BEC as assessment of binding by EEISA showed a correlation
between the number of bacteria added to the wells and the OD reading for both FITC-
labelled and unlabelled S. aureus. Direct visualisation of the bacteria by confocal
microscopy confirmed that the labelled bacteria were bound to the cells.
Binding indices were used to quantify the bacterial binding to cells. When the ratio of
bacteria per cell was increased from a lower to a higher level, the values for both the
percentage of positive cells and the mean fluorescence were increased. In contrast, when
the majority of cells bound bacteria the difference in bacterial binding between 2
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populations was clearer from values obtained for the mean. For the above reasons binding
indices were used to compare bacterial binding among individuals.
8.2.2 Inhibition of binding of S. aureus to BEC
Rosenstein et al. [1988] have reported that fucosylating the precursor type 1 to H and Le^
structures interfered with the binding of E. coli. There was a correlation of binding
between binding of a toxigenic strain of S. aureus to BEC from secretors and non-
secretors and binding of anti-Lea to their cells. Although anti-precursor type 1 and anti-
Lex significantly inhibited binding of bacteria, there was no correlation between binding of
bacteria and binding of these monoclonals to BEC. As binding of monoclonal anti-
precursor type 1 was not detected on BEC of all individuals regardless of their secretor
status, this suggests that precursor type 1 could be an additional site of recognition for the
bacterial adhesins rather than the major receptor. The possibility that the anti-precursor
type 1 and anti-Lex antibodies are binding to epitopes on structurally similar molecules
must also be considered.
Inhibition of bacterial binding by treatment of the target cells is always subject to criticism
that the antibodies are binding an epitope near the receptor and blocking access of the
bacteria. Experiments with either monoclonal and polyclonal antibodies are limited by this
potential problem. The subsequent use of anti-idiotypic antibodies to monoclonal Lea
supports the results of the inhibition studies with anti-Lea. Attempts to produce anti-
idiotypic antibodies to monoclonal anti-Lex or anti-precursor type 1 have been limited by
the cost of the monoclonal antibodies.
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8.2.3 Detection of Lewis antigens by flow cytometry
The results obtained by ELISA for Lea in secretions agreed with the detection of the
antigen on BEC by flow cytometry. BEC of secretors bound anti-Lea and there was
greater variability among results for the secretors compared with non-secretors.
There was much lower binding of the antibody to cells from Lewis negative individuals
whose cells were not agglutinated with anti-Lea or anti-Le^. These results suggest the
greater sensitivity of flow cytometry can detect small amounts of Lea or cross reactive
antigens on their cells which are insufficient for detection by the haemagglutination
reaction.
The flow cytometry method depends on the specificity of antibodies used to detect the
antigens of interest. Monoclonal antibodies are better than polyclonal ones for these
assays; however, if several monoclonals to a particular antigen are available, it would be
advisable to compare each for specificity with known positive and negative controls before
screening large numbers of samples.
8.2.4 Application of Synsorb-Lea to isolation of the adhesin
from S. aureus
Direct evidence for a specific receptor such as Lea makes it easier to isolate and purify the
bacterial adhesins. The Synsorb Lea bound a protein from cell wall preparations of a
toxigenic strain of S. aureus, the binding of which was inhibited by treatment of BEC with
anti-Lea; and this purified protein was able to block adherence of the bacteria to BEC.
This strain was also agglutinated by anti-idiotypic antibodies produced against monoclonal
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anti-Lea [Essery et al., 1994b]. The method might be applied to isolation of adhesins from
other bacteria or yeasts to which non-secretors appear to be at increased risk of infection.
8.3 The role of RSV in SIDS
RSV is a major contributor to winter peaks of infant deaths due to lower respiratory tract
infection [Anderson et al., 1989]. These infections are associated with apnoea in young
infants [Anas et al., 1982], Although there is no evidence that SIDS is caused directly by
RSV infection, the virus might enhance colonization by potentially pathogenic bacteria. In
addition to the native receptors for bacteria on the host cells, there is evidence that new
receptors for bacteria may be induced on virus-infected epithelial cells. The mechanisms by
which viruses enhance bacterial binding is unclear and is beyond the objectives of this
thesis; however, work by colleagues in the laboratory have identified 2 mechanisms by
which RSV infection enhances bacterial binding: 1) The glycoprotein G encoded by RSV
might be an additional receptor for bacteria; 2) RSV infection upregulates expression of
host cell antigens to which bacteria bind CD15 (Lex), CD14 and CD18 [Raza et al.,
1994], Further studies will assess the effect of antibodies to the G glycoprotein of RSV,
Lex, CD 14 and CD 18 on binding of staphylococci and pertussis to virus infected cells.
Virus infection might also potentiate the effect of bacterial toxins, both endotoxins and
exotoxins, as suggested by the work of Jakeman et al. [1991]. Interferon y induced by
virus infection enhances the endotoxin receptor (CD 14) on monocytes [Jackson et al.,
1993]. If release of inflammatory mediators in response to endotoxin is dose dependent,























Figure 8.1 Synergy between viral infection, endotoxins and pyrogenic toxins
resulting in release of inflammatory mediators.
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8.4 The role ofDPT immunization in SIDS
Results from this study indicate that B. pertussis and S. aureus have adhesins that bind to
Lea and Lex on epithelial cells. The pertussis toxin and the staphylococcal enterotoxin B
both bind to Lea and Lex. If the epitopes on the adhesins and/or toxins that bind to Lea
and Lex are structurally similar, immunization of infants against pertussis might induce
antibodies which could neutralize the staphylococcal antigens. Evidence from this
laboratory indicates that there is significant binding of anti-pertussis toxin to some of the
staphylococcal pyrogenic toxins [Essery et al., 1994b].
The age distribution of SIDS is associated with the time of immunization with DPT and
there are reports of SIDS occuring 24 hours after receiving the first dose of DPT [Bernier
et al., 1982; Baraff et al., 1983]. A number of epidemiological studies have indicated that
SIDS cannot be attributed to DPT immunization [Emery, 1981; Hoffman et al., 1987]. A
study by Walker et al. [1987] indicated that there was a six fold increased risk of SIDS in
unimmunised infants compared to immunised infants. If DPT immunization induces
antibodies that neutralize other toxins, earlier immunization might contribute to the recent
decrease in SIDS in Scotland since 1990.
8.5 Bacterial toxins and SIDS
Figure 8.2 summarizes the sequence of events that might lead to SIDS. The work in this
thesis has identified Lea antigen and RSV infection as two factors that might enhance
colonization of infants by B. pertussis and S. aureus. Mothers' smoking is another factor
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Figure 8.2 Possible role of pyrogenic toxins in SIDS.
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that might enhance bacterial colonization and it is significantly associated with SIDS.
Recent studies using the methods developed for bacterial binding studies have found
significantly increased binding of S. aureus to cells of smokers compared to cells of non-
smokers [Saadi et al., 1994].
Not all strains of staphylococci which colonize the epithelial cells are toxigenic, and not
every infant who is colonized by toxigenic staphylococci will become a SIDS victim.
There have to be additional factors that precipitate the chain of events leading to cot
death. These toxins are only produced between 37 - 40°C and the temperature of the
mucosal surfaces are usually below the permissive temperature due to passage of air
during breathing. The infant's body temperature might be increased by concurrent minor
respiratory infection and this effect could be increased by over-wrapping [Fleming et al.,
1990] or placing the infant in the prone position [Gilbert et al., 1992] which might reduce
heat loss through the face or block a nostril creating a "micro-environment" in which the
permissive temperature is reached. Pyrogenic toxins are thought to act directly on the
brain to raise the temperature. This could result in amplification of toxin production as
greater amounts are present at 40°C than at 37°C.
The mechanisms by which the microorganisms might cause sudden death are summarised
in Figures 8.3. The pyrogenic toxins are superantigens that induce inflammatory mediators
via their action on monocytes and T cells (e.g., TNF, nitric oxide and IL-1 (Figure 8.3).
The effect of respiratory infection, increasing the duration of sleep apnoea, and increasing
the risk of SIDS, could be mediated through the somnogenic effects of EL-1 [Guntheroth,
1989]. There is no direct biochemical evidence that IL-1 is increased in SIDS's sera;
however, systemic release of IL-1 causes disturbances of hormonal control [Cunningham














Deep sleep & apnoea
Figure 8.3 Summary of mechanisms by which microorganisms might cause sudden
death.
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serum Cortisol among SIDS victims. The actions of IL-1 include: induction of fever;
increased the production of TNF, IL-6 and IL-8 [Kluger, 1991]; and induction of
haemodynamic shock [Ikejima et al., 1989].
TNF might induce heat shock and is probably a major factor in the induction of toxic
shock. It can also cause severe hypoglycaemia which could result in glucose starvation in
the brain [Stevens et al., 1993]. The pyrogenic toxins can enhance the effect of endotoxin
by 100,000 fold [Bohach et al., 1990], The scheme outlined in Figure 8.3 could explain
the synergistic effects of S. aureus exotoxins and endotoxins of E. coli in the chick
embryo model [Drucker et al., 1992],
8.6 Prophylaxis of SIDS
The preventive measures currently recommended fit the hypothesis proposed for SIDS.
Discouraging the prone sleeping position and measures to avoid over heating babies might
reduce the probability that the toxins are induced. Discouraging smoking among mothers
and other people living with the infant will reduce risk of respiratory infection.
Encouragement of breast feeding will reduce risk of infection. Infants who experienced
apnoea should be monitored and examined for carriage of toxigenic bacteria. Early
immunization for DPT might induce antibodies that reduce colonization or partially
neutralize toxins.
8.7 Further studies
It is important to test the immunogenicity of the adhesins that bind Lea. ELISA techniques
will be used to determine if there is an immune reaction to these adhesins in the sera and
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secretions of SIDS victims compared with healthy infants and adults. Assessment of
human milk for antibodies or glycoconjugates that inhibit the adhesin could help explain
the protective effect of breast feeding. Polyclonal and monoclonal antibodies to the
adhesins can be produced and used to screen the bacteria isolated from the SIDS victims
and healthy infants for the expression of the adhesins. The antibodies can be tested in
attachment assays to determine if they reduce bacterial binding.
Epidemiological studies have been initiated to determine if factors associated with
enhanced binding of B. pertussis and S. aureus (expression of Lea, RSV infection, mother
smoking) are reflected in isolation of potentially pathogenic bacteria from healthy infants.
These studies combined with laboratory investigations on the increased binding of
staphylococci and pertussis to RSV-infected cells will provide insights into the
associations between minor respiratory infection and SIDS.
The hypothesis proposed can be tested, but it will require cooperative studies between
research workers in a variety of related disciplines, microbiology, immunology,
developmental physiology and epidemiology.
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SUMMARY
Toxigenic strains of Staphylococcus aureus have been suggested to play a role in
sudden infant death syndrome (SIDS). In this study we examined two factors that
might enhance binding of toxigenic staphylococci to epithelial cells of infants in
the age range in which cot deaths are prevalent: expression of the Lewisa antigen
and infection with respiratory syncytial virus (RSV). By flow cytometry we
demonstrated that binding of three toxigenic strains of S. aureus to cells from non-
secretors was significantly greater than to cells of secretors. Pre-treatment of
epithelial cells with monoclonal anti-Lewisa or anti-type-1 precursor significantly
reduced bacterial binding (PcOOl); however, attachment of the bacteria
correlated only with the amount of Lewis3, antigen detected on the cells (P < OOl).
HEp-2 cells infected with RSV bound significantly more bacteria than uninfected
cells. These findings are discussed in context of factors previously associated with
SIDS (mother's smoking, bottle feeding and the prone sleeping position) and a
hypothesis proposed to explain some cases of SIDS.
INTRODUCTION
The suggestion that microorganisms are involved in the aetiology of some cases
of sudden infant death syndrome (SIDS) is based on evidence from a variety of
epidemiological and pathological studies. SIDS occurs during the period when
maternal antibodies have declined and the infant immune system is immature.
There is a marked seasonal variation in SIDS; the risk increases in autumn and
winter when respiratory infections are more common [1, 2]. There is often a
history of upper respiratory tract infection in these infants [3]. Mother's smoking
was identified as a factor for SIDS in the New Zealand studies [4]. Smoking and
passive exposure to cigarette smoke have been associated with increased risk of
respiratory tract infections [5] and with carriage of potentially pathogenic
microorganisms [6, 7]. At post-mortem examination, there is often evidence of
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minor inflammation and infection of the respiratory tract in many SIDS infants
[8],
There are conflicting results on the role of viruses [9. 10] and toxigenic intestinal
bacteria in SIDS [11-15]. Recently, it has been suggested that nasopharyngeal
colonization by toxigenic strains of Staphylococcus aureus, particularly those
producing the toxic shock syndrome toxin 1 (TSST-1). might be involved in some
of these infant deaths [16]. Pyrogenic toxins are produced by many strains of S.
aureus, and similar ones are found among some strains of group A /f-haemolytic
Streptococcus pyogenes. These are "superantigens' that have significant physio¬
logical effects such as induction of fever (> 38 °C), possibly by direct action on the
hypothalamus or by their induction of tumor necrosis factor (TNF) and
interieukin-1 by monocytes [17]. S. aureus was isolated from a higher proportion
ofSIDS infants (41-3%), compared with a control population (28-3%) [18]. In this
study we examined two factors that might enhance density of colonization by
toxigenic staphylococci in infants during the period when they are at risk of SIDS:
expression of the Lewisa blood group antigen, and infection with respiratory
syncytial virus (RSV).
Non-secretion, the genetically controlled inability of an individual to secrete the
glycoprotein form of his/her ABO blood group antigens, is associated with
susceptibility to a number of bacterial diseases and with asymptomatic carriage
of some potentially pathogenic microorganisms [19], including group A strepto¬
cocci [20]. The secretor gene also influences expression of the Lewis blood group
antigens: non-secretors produce only Lewis3,; secretors produce Lewis" pre¬
dominantly but also variable amounts of Lewis3. The amount of Lewis3, present in
secretors depends on the relative activities of the fucosyl transferases coded for by
the secretor gene and the Lewis gene. If the secretor fucosyl transferase acts first
on the precursor chain, the Lewis enzyme can add fucose to the subterminal sugar
of the chain to produce Lewis". If the Lewis fucosyl transferase acts on the
precursor first, the Lewis3, molecule cannot act as a substrate for the secretor
enzyme.
One of the hypotheses proposed to explain the increased proportion of non-
secretors among carriers of some potentially pathogenic bacteria and yeasts is that
the Lewis3, antigen is one of the host cell receptors for some microorganisms [19.
21. 22]. In this context, the reported high proportion of infants expressing Lewis
antigens during the first year of life was of particular interest [23]. Among infants,
the enzyme coded for by the secretor gene appears to be less efficient than that
coded for by the Lewis gene. Although the majority of infants are secretors
(7;5-80%). during the first year of life they will express easily detectable amounts
of Lewis3. The peak in the proportion of infants expressing Lewis3 is 2-4 months,
similar to the highest incidence of cot deaths.
It has been reported that both natural and experimental viral infections
enhance colonization by S. aureus [24]. RSV infected cells bind greater numbers
of Neisseria meningitidis and type b Haemophilus influenzae compared with
uninfected cells [25]. As RSV infects almost half of all infants by the age of 12
months and is most prevalent in the winter months [26], it is an obvious candidate
for investigation of the role viruses might plav in enhanced colonization by
toxigenic bacteria.
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These observations prompted the following questions:
1. Is Lewis3, detected in SIDS infants 1
2. Do strains of toxigenic S. aureus bind in greater numbers to non-secretor cells
expressing larger amounts of Lewis3?
3. As some viral infections increase carriage of staphylococci, do tissue culture
cells infected with RSV bind greater numbers of staphylococci than
uninfected cells ?
The results of these investigations are discussed in the context ofepidemiological
data on the role of microorganisms in SIDS.
SUBJECTS AND METHODS
Respiratory tract secretions (89) obtained from SIDS infants during autopsy
were provided by Dr J. X. Inglis and Dr P. Molvneaux (Regional Virus
Laboratory, City Hospital. Edinburgh) and by Dr A. Gibson (Royal Hospital for
Sick Children. Glasgow). These were examined for presence of H [27] and Lewis
antigens [28] by enzyme-linked immunoassays (ELISA) described previously.
S. aureus strains XCTC 10652. NCTC 10654. NC'TC 10655. NCTC 10656. NCTC
10657. XCTC 11965. and XCTC 8532 were obtained from Dr A. Wieneke Central
Public Health Laboratory, Colindale. Strains 40654 and 41206 were kindly
provided by Dr J. Medcraft. Public Health Laboratory Service. Department of
Microbiology, Reading, Berkshire. The strains and the toxins they produced are
listed in Table 1. The bacteria were grown on nutrient agar or for some
experiments on blood agar to examine the effect of medium on binding to
epithelial cells.
Buccal epithelial cells (BEC) were obtained from pairs of healthy secretor and
non-secretor donors matched as closely as possible for ABO blood group, age and
sex. ABO groups of the donors were determined by slide agglutination of
erythrocytes with monoclonal anti-A and anti-B antibodies (Scottish Xational
Blood Transfusion .Service). Secretor status was determined from saliva by
haemagglutination inhibition assays [29], initially confirmed by tube aggluti¬
nation with monoclonal anti-Lewis3 or anti-Lewisb antibodies (Scottish Xational
Blood Transfusion Service) and later by ELISAs for H and Lewis antigens.
BEC were collected by rubbing the inside of the cheeks with cotton swabs. To
remove the cells, the swabs were agitated in 10 ml phosphate-buffered saline
(PBS) (pH 7-2). They were washed twice in PBS in a Sorvall RT 6000 centrifuge
(300 g for 10 min) and the concentration adjusted to 2 x 105 ml-1 after de¬
termination of the number of cells microscopically in an improved Xeubauer
haemocvtometer.
Bacteria were labelled with fluorescein isothiocynate (FITC) by a modification
of the method ofWright and Jong [30]. A heavy suspension of bacteria in PBS was
prepared and washed twice by centrifugation at 1000 g for 20 min. The bacterial
pellet was resuspended in 4 ml of a freshly prepared 0-04% solution of FITC in
sodium carbonate (0-05 m) and sodium chloride (0*1 m) (pH 9-2). The mixture was
incubated at 37 °C for 20 min and washed twice with PBS. The pellet was
510 A. T. Saadi and others
resuspendecl in PBS and filtered through a Millipore membrane filter (5 /tra pore
size) to remove clumps of bacteria.
The bacterial concentration was determined by measuring the optical density of
the suspension at 540 nm. The linear relationship between optical density and
total count was determined for each strain.
Binding of bacteria to BEC of secretors and non-secretors
BEC (200 /d) were mixed with 200 /tl of the FITC-labelled bacteria at the
following ratios of bacteria per cell: 80:1, 160:1 and 320:1. The mixtures were
incubated at 37 °C for 30 min with gentle shaking in an orbital incubator
(Gallenkamp). The cells were washed twice with PBS by centrifugation at 300 g
for 10 min to remove unattached bacteria. The samples were resuspended in 300 /d
I % buffered paraformaldehyde (Sigma) and stored in the dark at 4 °C until
analysed.
Analysis of binding assays
Each sample was analysed by flow cytometry with an EPICS-C (Coulter
Electronics. Luton. LTIv) equipped with a 5 W laser with a power output of
200 MW at 488 nm. Cells were selected from a display of forward angle light
scatter (size) versus 90° light scatter (granularity) by means of a bitmap. The
bitmap included the main population of the cells and excluded debris and clumps
from further analysis. The percentage of cells with fluorescence greater than
background level was recorded on a one-parameter histogram which measured
fluorescence on a logarithmic scale. The mean fluorescence channel values for
positive cells were obtained from a one-parameter histogram measuring fluor¬
escence on a linear scale. The results were analysed by Immunoanalysis (Coulter),
a computer programme that subtracts the values of the control population from
the test population at each channel of the two histograms. The binding index (BI)
of each sample was calculated by multiplying the percentage of fluorescent cells by
the mean fluorescence channel value.
Inhibition of bacterial binding
BEC obtained from secretors or non-secretors were treated with monoclonal
anti-Lewisa (LAI 112/161.8. kindly supplied by Dr R. H. Fraser. Law Hospital.
Carluke) or monoclonal antibody to the type I precursor chain (anti-precursor
type 1) (clone no 619/102. Russel Fine Chemicals. Chester) for 60 min at 37 °f.
After washing twice by centrifugation at 300 g for 10 min. the attachment assay
was performed and analysed as described above.
Binding of bacteria to HEp-2 cells
Methods for assessment of binding of S. aureus strains XCTC 8532 and NCTC*
10655 to uninfected and RSV-infected HEp-2 tissue culture cells and analysis of
results were as described for II. influenzae [25].
Detection of Lewis" and type I precursor antigens on BEC of seeretor and non-
secretor donors
Buccal epithelial cells (200 /tl. 2 x 10° ml-1) from 7 secretors. 7 non-secretors and
3 secretor donors whose erythrocytes were not agglutinated by either anti-Lewisa
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or anti-Lewisb monoclonal antibodies (Scottish National Blood Transfusion
Service) (Lewis-negative individuals) were incubated with 200 /<1 of monoclonal
antibodies to Lewis" (1/5) or precursor type I (1/10) for 60 tnin at 37 °C. The cells
were washed twice with PBS at 300 g for 10 min and incubated with 200 /d rabbit
anti-mouse IgM conjugated with FITC (1/200) (Sigma). The FITC-labelled
antibody was also added to 200 /d of cells which had not been treated with the first
antibody as a control. After 30 min incubation in an orbital shaker at 37 °C. the
cells were washed twice with PBS. They were resuspendecl in 300 /d 1 % buffered
paraformaldehyde and stored in the dark at 4 °C until analysed. The cells were
analysed on an EPICS-C flow cvtometer as described above and the binding
indices calculated as before.
Statistical methods
All analyses were carried out on the logarithms of the binding indices which
conformed more closely to a normal distribution than the raw values. Differences
between groups were tested by paired or unpaired t tests as appropriate, and
confidence limits for the mean values in one group were expressed as a percentage
of those in the other by taking antilogarithms. Analysis of covariance was used to
test whether binding levels were associated with the amount of anti-Lewis" in
secretors and non-secretors tested on different days, while the association in a
similar experiment with anti-precursor on a single clay was tested by Pearson
correlation. Three-factor analysis of variance was used to test whether RSV
infection was related to binding of HEP2 cells at two different concentrations of
bacteria per cell.
RESULTS
Detection of Leivis" antigen in body fluids of SIDS infants
Lewis" antigen was detected in 63/89 (71%) of the specimens from SIDS
infants.
Binding of S. aureus to epithelial cells of secretors and non-secretors
The results of the binding assays are presented in Table 1 as the 95% confidence
limits for binding of the bacteria to non-secretor cells expressed as a percentage of
binding to cells from matched secretors. Confidence intervals for which both
values are above 100 indicated significant evidence that cells from non-secretors
bound more staphylococci than cells from secretors.
There was no significant difference in binding to cells of non-secretors compared
with binding to cells of secretors observed for the non-toxigenic strain NCTC 8532
or five of the toxin producing strains: NCTC 41206. NCTC 40654. NCTC 10654.
NCTC 10656 and NCTC 10652. Three of the toxigenic isolates NCTC 10655. NCTC
11965 and NCTC 10657. showed higher binding to cells from non-secretors
compared with binding to cells from secretors (Table 1). There was significantly
higher binding of NCTC 10655 and NCTC 10657 to non-secretor cells at all ratios
of bacteria: cells tested, while for strain NCTC 11965 there was significantly higher
binding to cells of non-secretors only with the lowest ratio of bacteria.
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Table 1. 9o°0 confidence limits for binding of Staphylococcus aureus to non-
secretor ceils expressed as a percentage of binding to cells from matched secretors
Bacteria per cell
A
Strain no. Toxin produced 80 160 320
NCTC 8532 — 66-145 69-146 31-182
NCTC 10652 A 63-198 63-227 50-301
NCTC 10654 B 67-153 75-185 75-206
NCTC 10655 C 138-228t 107-249* 107-237*
NCTC 10656 D 61-136 79-175 67-178
NCTC 10657 A, B 110-197* 101-161* 117—165t
NCTC 11965 A. TSST-1 102-201* 92-192 81-203
40654 A 82-182 54-189 91-222
41206 B 74—147 75-172 74—158
* P < 0-05; t P < 0-01.
r—t—T—v
Subjects
Fig. 1. Binding of monoclonal anti-Lewis" antibody to epithelial cells of non-secre-
tors (£3), secretors (H) and Lewis"'0" (B) secretors.
Binding of anti-Lewisa or anti-precursor antibody to epithelial cells of secretors and
non-secretors
The epithelial cells from the three individuals whose erythrocytes were not
agglutinated by either anti-Lewisa or anti-Lewisb (Lewis-negative) bound
consistantly low levels of anti-Lewisa. Cells from non-secretors bound high levels
of the antibody. While the mean binding index for secretors (36707) was
approximately half that for non-secretors (79148), there was considerable
variation in the amount of antibody bound by individual secretors (Fig. 1). There
was no consistent pattern of binding of the anti-precursor monoclonal to cells of
secretors. non-secretors or Lewis-negative individuals.
Inhibition of bacterial binding
Binding of <8. aureus NCTC 10655 to BEC obtained from 7 secretors of 7 non-
secretors treated with anti-Lewisa antibody was significantly lower compared with
binding of the bacteria to untreated cells from the same donors (t = —4-46.
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d.f. = 13. P < 0-001.95% CI 55-81 %). A similar pattern was observed for binding
of XCTC 10655 to cells of 7 non-secretors and 10 secretors treated with monoclonal
anti-precursor type 1 compared with untreated cells (t = 8-19. d.f. = 16.
P < 0-001. 95% CI 58-72%).
Binding of XCTC 8532 to the cells from the same donors treated with anti-
Lewisa antibody was significantly lower compared with binding of the bacteria to
untreated cells (t = —4-97. d.f. = 11. P < 0-001. 95% CI 43-72%). Inhibition of
NCTC 8532 with anti-precursor was not examined because of the limited amount
of antibody.
Binding of bacteria with reference to detection of Lewisa antigen or precursor
antigen
Binding ofS. aureus NCTC 10655 was correlated with the amount of monoclonal
anti-Lewisa antibody detected on the BEC of secretors and non-secretors (d.f. =
12. t — 5-03, P < 0-001). A similar pattern was found with NCTC 8532 (t = 4-24.
d.f. = 12. P < 0-001). There was no significant correlation between the amount of
anti-precursor detected on epithelial cells and binding of NCTC 10655 or NCTC
8532.
Binding of S. aureus to RSV infected cells
Strains NCTC 8532 and NCTC 10655 were assessed in seven experiments to
compare binding of bacteria to HEp-2 cells and RSV-infected HEp-2 cells. For
both isolates the binding indices were greater for the virus infected cells: NCTC
8532 (P < 0-001. 95% CI 117-155%), NCTC 10655 (P < 0-05. 95% CI 109-
155%).
DISCUSSION
The results provided information for the three questions to be investigated in
this study. Lewis3, antigen was detected in secretions of 71% of SIDS infants
examined. There was increased binding of some toxigenic strains of S. aureus to
epithelial cells from non-secretor donors: and RSV-infected cells bound more
staphylococci than uninfected cells.
The lack of relevant control populations is a major criticism of epidemiological
studies of cot deaths. There is. however, evidence from several surveys that S.
aureus is isolated from the nasopharynx of approximately 35-40% of SIDS
infants [16. 18. 31] compared with 28% from healthy infants [18]. TSST-1 has
been demonstrated in the renal tubular cells of some SIDS infants but not in a
comparison group of infants who were not cot death victims [32]. The pyrogenic
toxins of S. aureus and group A streptococci are powerful ' superantigens' that can
induce release of cytokines that might trigger a cascade of events leading to shock
or damage to the respiratory or cardiac systems [17].
Because density of colonization might be an important consideration in the
hypothesis that these toxins play a role in some cot deaths, factors suggested to
enhance colonization were assessed in the study reported here. Non-secretors of
ABO blood group antigens are over-represented among carriers of group A
streptococci [20]. We tested the hypothesis that epithelial cells from non-secretor
donors might bind greater numbers of toxigenic staphylococci than cells from
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secretors. Three of the eight toxigenic strains, including one producing TSST-1.
did show significantly higher binding to non-secretor cells.
Attachment of strain XCTC 10655 which bound in greater numbers to non-
secretor cells was significantly inhibited by pretreatment of the host cells with
either monoclonal anti-Lewisa antibody or monoclonal anti-precursor type-1
antibody. Anti-precursor type 1 antibody was examined because it has been
suggested that bacteria might bind to the precursor portion of the ABO or Lewis
blood group antigens: and glycosylation of the precursor to H or Lewis antigens
decreased the accessibility of the binding site [33], There was a significant
correlation between binding of XCTC 10655 and binding of anti-Lewisa antibodyo o «/
to the host cell, but there was no correlation between binding of this strain with
the amount of anti-precursor antibody detected on the cells. As the anti-precursor
monoclonal was prepared by immunization with Lewisa antigen, the inhibition of
bacterial binding observed following pretreatment of cells with anti-precursor
might be due to cross-reactivity with Lewisa although none was indicated by the
manufacturer.
Although XCTC 8532 did not bind in greater numbers to non-secretor cells
compared with secretor cells, its binding was inhibited by treatment of the
epithelial cells with anti-Lewisa and there was a significant correlation between its
binding to the donor cells and the amount of anti-Lewisa antibody bound by the
cells. From Fig. 1. it is apparent that some secretors bind as much anti-Lewis" as
most non-secretors. For the experiments comparing the binding of staphylococci
to cells from secretors and non-secretors. the donors were matched only according
to sex. age and ABO blood group: and the same pairs of secretor/non-secretor
donors were not available for each experiment. At that time there was no
information on the amount of anti-Lewis" bound by the cells of individual donors.
Early experimental work suggested that there are multiple receptors for
staphylococci on human epithelial cells [34], If Lewis" is one of the receptors for
some strains of staphylococci or group A streptococci capable of producing
pyrogenic toxins, the expression of this antigen among young infants might
enhance their colonization by these bacteria. Viral infections have been shown to
enhance carriage of staphylococci [24]; and disease due to TSST-1 has been
reported to follow influenza or "flu-like" illnesses [35]. Binding of both
meningococci and type b H. influenzae to tissue culture cells derived from human
epithelium (HEp-2) was substantially increased if the cells were infected with RSV
[25]: and. in this study, both the toxigenic and non-toxigenic strain tested bound
in greater numbers to the RSV infected cells. If there are similar interactions in
rivo. infection with RSV common during the first year of life might also enhance
colonization by these bacteria.
These studies suggest two factors that might enhance staphylococcal colon¬
ization ofyoung infants: however, all infants who become colonized do not become
SIDS victims. The following hypothesis is an attempt to correlate our laboratory
findings with factors identified in epidemiological studies of cot deaths in Xew
Zealand: mother's smoking, prone sleeping position and bottle feeding [4].
Mother's smoking which was associated with carriage of meningococci among
children [36] might increase the risk of initial exposure to potentially pathogenic
bacteria in two ways. First, epithelial cells from smokers have been shown to bind
Toxigenic S. aureus and Leivisa in SIDS 515
greater numbers of staphylococci than cells from non-smokers [37]. Smoking also
enhances susceptibility to respiratory viral infections: and epithelial cells from
individuals with natural or experimental viral infections bound more staphy¬
lococci compared with those from individuals who were not infected with a virus
[37].
In addition to the two factors examined in the present study, others that might
enhance density of colonization of infants by staphylococci include passive
exposure to cigarette smoke which decreases mucocilary clearance. Infants in the
age range in which the peak of SIDS occurs have little or no mucosal or systemic
immunity to staphylococci or to the pvrogenic toxins. The effect of breast feeding
on carriage of staphylococci or susceptibility to these toxins is unknown: however,
in studies on the possible role of toxigenic Clostridia in cot deaths. Clostridium \
difficile was isolated from significantly fewer breast fed infants compared with
formula fed infants, and CI. difficile toxin was detected only in the faeces of
formula-fed infants [38]. —
The pyrogenic toxins are produced between 37-40 °C; and they are produced in
greater quantities at the higher temperatures [17]. Three factors associated with
SIDS might increase the infant's temperature and thereby enhance toxin
production: respiratory infection: overwrapping with clothing or bedding; and
the prone sleeping position. In the prone sleeping position, infants lose less heat
than in the supine position. [39-41]. The synergistic effect between increased
temperature and increased toxin production might account for the high
temperatures recorded for some of these infants at autopsy. Among 34 infants who
died suddenly and whose rectal temperatures were measured immediately before
refrigeration. 10 had temperatures > 38 °C and 5 were > 40 °C [42]. In addition
to the heat-shock hypothesis of cot death, the increased release of IL-1 induced by
the toxins might contribute to prolonged sleep apnoea as suggested bv Guntheroth
[43],
Studies are underway to assess levels of Lewis3, in saliva of infants, exposure to
cigarette smoke and presence of RSV on carriage of toxigenic staphylococci and
streptococci. Results of these studies should provide evidence to refute or confirm
the scheme proposed.
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Abstract: A 67 kDa protein was isolated from cell membrane preparations of Staphylococcus aureus (NCTC 10655) by affinity
adsorption with synthetic Lewis a antigen conjugated to Synsorb beads. Pre-treatment of buccal epithelial cells expressing Lewis a
with the purified protein reduced binding of the staphylococcal strain to a greater extent than the material not bound to the
Synsorb beads. The significance of this work is discussed with reference to expression of Lewis a antigen in infants and the
proposed role of toxigenic strains of staphylococci in some cases of sudden infant death syndrome.
Key words: Staphylococcus aureus; Adhesin, Lewis a; Blood group antigen; Sudden infant death syndrome
Introduction
The role of microorganisms in the aetiology of
sudden infant death syndrome (SIDS) has been
investigated over many years, but the evidence
that a single microorganism is responsible for
these infant deaths remains inconclusive. Several
of the factors identified in epidemiological stud¬
ies of SIDS are associated with increased suscep¬
tibility of infants to infectious diseases. SIDS
*
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occurs most commonly in the vulnerable period
when maternal antibodies in the infant have de¬
creased and the immune system is immature.
SIDS also occurs more frequently during the win¬
ter months when respiratory viral infections are
most prevalent. These infections are likely to be
exacerbated by exposure to cigarette smoke, and
mother's smoking has been identified as a risk
factor in SIDS. Breast-fed infants are not only
less vulnerable to gastro-intestinal and respira¬
tory infections but also less susceptible to SIDS
[1].
By definition, invasive bacterial diseases are
not the cause of SIDS, but some studies have
suggested a role for toxin-producing bacteria such
SSDI 0928-8244(94)00006-F
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as Clostridium botulinum [2,3], Escherichia coli
[4-7] and Staphylococcus aureus [4,8-10]. Some
strains of S. aureus and group A Streptococcus
pyogenes [11] produce pyrogenic toxins which act
as superantigens that have significant physiologi¬
cal effects on the host, e.g. toxic shock syndrome.
Epidemiological studies have found that indi¬
viduals who are non-secretors of the ABO blood
group antigens are over-represented among pa¬
tients with some bacterial diseases and among
carriers of some potentially pathogenic bacteria.
The Lewis a antigen, usually present in greater
quantities on epithelial cells of non-secretors,
might be a receptor for some adhesins on strains
of these bacterial pathogens. If so, individuals
who express significant amounts of Lewis a might
be more readily or more densely colonized by
these organisms [12,13],
Previous studies have shown that binding of
both toxigenic and non-toxigenic strains of S.
aureus to epithelial cells was correlated with the
amount of Lewis a antigen detected on the cells,
and monoclonal antibody to this antigen can block
attachment of these bacteria [14], In this study an
attempt was made to isolate the surface compo¬
nent of S. aureus that binds Lewis a and to use it




Lyophilized S. aureus strains NCTC 10655,
NCTC 10652 and NCTC 8532 were obtained
from the Central Public Health Laboratory, Col-
indale. Bacteria were cultured on nutrient agar
for 24 h at 37°C. Colonies were emulsified in
Microbank beads and kept at — 20°C for further
use. A fresh bead was used to inoculate plates for
each experiment.
Cell wall isolation
A modification of the method described by
Cheung et al. [15] and Sharp and Poxton [16] was
used. Colonies were suspended in washing buffer
(0.05 M Tris-HCl, 0.025 M MgCl2 and 0.15 M
NaCl, pH 7.6) and centrifuged for 20 min at
2000 Xg at 4°C. The bacterial pellet (2 g) was
suspended in freshly prepared washing buffer
containing DNAse 1 (50 /xg ml-1) (BDH, 39012)
and RNAse (50 /xg ml-1), (Calbiochem, lot
902237). The pre-cooled (4°C) cell suspension was
passed twice through a French Pressure Cell
(Aminco American Instrument Co., Silver
Springs, MD) at 107 pa = 6000-7000 lb/ in2 and
centrifuged at 2000 X g for 20 min at 4°C to
remove any intact bacteria. The supernate was
centrifuged at 20 000 X g for 30 min to recover
the cell wall material. The resulting pellet was
washed 3 times in ice-cold distilled water by
centrifugation at 30000 Xg for 15 min at 4°C.
Extraction of cell wall protein
The pellet from the crude cell wall preparation
was suspended at room temperature in 5 ml of
2% (v/v) Triton X-100 (Sigma T-6878) in water
for 30 min and centrifuged at 20000Xg for 20
min. After two such extractions, the pellet was
dissolved in 5 ml of a freshly prepared solution
containing 50 /xg mL1 lysostaphin (Sigma L-7386)
in 0.05 M Tris-HCl with 0.145 M NaCl (pH 7.6)
and incubated at 37°C for 2 h with continuous
shaking. After centrifugation at 45 000 X g for 20
min at 4°C, the supernate was freeze-dried, re¬
constituted in distilled water and stored at — 20°C.
Polyaery lamide gel electrophoresis (PAGE)
The buffer system of Laemmli [17] with 10%
w/v acrylamide in a Biometra-Minigel (Biometra,
Wagen-Stieg, Gottingen, FRG) was used. Protein
content was determined by the method of Brad¬
ford [18] with bovine serum albumin as standard.
Samples (20 /x 1) containing 8 /xg protein were
applied to the gel, run for 1-2 h at 60 V for the
stacking gel and 150 V to complete the run and
stained with Coomassie brilliant blue. Molecular
mass markers for molecular masses 30000 to
200000 (Sigma, mw-SDS-200) were run with each
gel.
Purification of adhesins by affinity adsorption
Synthetic Lewis a covalently bound to Synsorb
affinity adsorbent (100 mg) (ChemBiomed Ltd.,
Edmonton, Alberta, Canada; lot ASi-137) was
swollen in a Falcon tube in 2 ml of phosphate
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buffered saline (PBS) (pH 7.2) for 2 h at room
temperature with continuous rotation. The beads
were centrifuged at 50 X g for 5 min and the
supernate removed. The protein extract (0.17 mg
in 1 ml) from strain NCTC 10655 was added to
the beads, rotated overnight at 4°C and cen¬
trifuged at 50 Xg for 5 min. The supernate con¬
taining unbound material was collected. The
beads were washed twice with 2 ml of PBS and
the washings added to the unbound material. The
bound material was eluted from the beads with 1
ml of 2% (v/v) ammonia (25% solution, BDH) in
saline for 20 min with continuous rotation at
room temperature. The supernate was recovered
by centrifugation at 50 X g for 5 min. The beads
were finally washed with 2 ml of PBS and the
eluate added to the previous supernate. The orig¬
inal sample and all extracts were freeze-dried,
reconstituted in distilled water and dialysed
overnight against Tris-HCl (0.01 M, pH 7.4) at
4°C.
Inhibition assay
The affinity purified extract (protein) and the
unbound material of NCTC 10655 prepared as
above were made up to a protein concentration
of 15 pg ml"1. A volume (100 /ul) of each was
added to 100 p\ of suspensions of buccal epithe¬
lial cells (BEC) (2.5 X 105 ml"1) taken from 2
healthy individuals expressing Lewis a. Cells incu¬
bated with 100 p\ of PBS were included as un¬
treated controls. The mixture was incubated for 1
h at room temperature. The cells were washed
twice with PBS by centrifugation at 300 X g for
10 min. 5. aureus NCTC 10655 cells (100 p\)
labelled with fluorescein isothiocyanate (FITC)
by the method described previously [14] were
added to the BEC at a ratio of 640 bacteria per
cell. After 30 min at 37°C with continuous shak¬
ing, the cells were washed twice with PBS, fixed
with 1% v/v paraformaldehyde and analysed by
flow cytometry in an EPICS C (Coulter Ltd., UK)
as previously described [14], The binding index
(BI) for each sample was calculated by multiply¬
ing the percentage of fluorescent cells by the
mean fluorescence channel of the positive popu¬
lation. The percent inhibition was calculated by
the formula 100 - [(BI test/BI control) X 100],
Results
Cell wall preparations
The protein profiles by PAGE of the material
solubilised by lysostaphin from strains NCTC
10655, NCTC 10652 and NCTC 8532 are shown
in Fig. 1. The band at 28 kDa is the lysostaphin.
All three strains showed numerous common
bands.
Figure 2 shows the peptide bands of strain
NCTC 10655 before and after adsorption with
Synsorb Lewis a. The bands for the unbound ma¬
terial (track 2) and the original cell wall material
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Fig. 1. Coomassie brilliant blue-stained SDS-PAGE (10%) of
proteins (8 /xg) extracted from S. aureus NCTC 10655 (lane
1), NCTC 10652 (lane 2), NCTC 8532 (lane 3).
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(track 1) show similar patterns of multiple bands
while the eluate (track 3) has a major band of
approximately 67 kDa. The protein concentration
of the original cell wall extract was 170 jug ml-1
and that of the unbound material and Synsorb
eluate were 150 jug ml-1 and 15 /xg ml-1 respec¬
tively.
Inhibition studies
The ability of the protein preparations to in¬
hibit binding of S. aureus NCTC 10655 to buccal
epithelial cells was assayed by flow cytometry. In
each of 3 experiments, the percentage inhibition




Fig. 2. Coomassie brilliant blue-stained SDS-PAGE (10%) of
cell wall extracts of 5. aureus NCTC 10655 (lane 1), unbound
material (lane 2), and Synsorb-Lewis a eluate (lane 3).
Table 1
Inhibition of binding of S. aureus NCTC 10655 by pretreat-
ment of buccal epithelial cells (BEC) with protein prepara¬
tions eluted from Synsorb-Lewis a and the unbound material
Experiment % Inhibition
Whole extract Unbound Synsorb-Lewis a
(15 /xg/ml-1) protein eluate
(15 fig/mL ') (15 fig/mL1)
1 44.8 25.5 54.8
2 ND * 6.5 24
3 ND 13.3 25.7
* ND = not done.
was greater for the protein eluted from Synsorb
Lewis a (Table 1). The eluate from a control
preparation obtained by passing lysostaphin solu¬
tion through the Synsorb beads showed no bands
and no inhibition of bacterial binding to the buc¬
cal epithelial cells.
Discussion
The Synsorb Lewis a affinity purification iso¬
lated a major polypeptide of 67 kDa from cell
wall preparations of S. aureus. This supports our
previous work which has shown that binding of S.
aureus strains to buccal epithelial cells was signif¬
icantly correlated with the amount of Lewis a on
the cells and binding of both NCTC 10655 and
NCTC 8532 to these cells could be significantly
reduced by pre-incubation of the cells with mono¬
clonal anti-Lewis a [14], The results also comple¬
ment the studies in which these strains were
agglutinated by anti-idiotypic antibodies pro¬
duced by immunization of mice with monoclonal
anti-Lewis a [19].
The cell wall preparations were capable of
inhibiting attachment of strain NCTC 10655 to
buccal epithelial cells; the inhibitory activity of
the material eluted from Synsorb Lewis a was
greater than that of the unbound material. Com¬
plete inhibition of binding was not predicted as
Gram-positive bacteria express multiple adhesins
[20,21], Teichoic acids, protein A and fibronec-
tin-binding proteins have been implicated in ad¬
herence [20,22,23], The molecular mass of the
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Table 2
ABO and Lewis blood group antigens present on cells and in
body fluids of secretors and non-secretors
Antigen Secretor Non-secretor
Cells Body fluids Cells Body fluids
H + + + -
A/B + + + -
Lewis a + /- + /- + +
Lewis b + + - -
Lewis a adhesin (67 kDa) differs from those re¬
ported for fibrinogen or fibronectin-binding pro¬
teins: 18 kDa [24]; 19 kDa [25]; 62 kDa [26]; and
200 kDa [27].
Lewis antigens are present on epithelial cells
of approximately 95% of most human popula¬
tions. Expression of the Lewis antigens, Lewis a
and Lewis b, is modified by the secretor gene
(Se); both the Se and Lewis (Le) genes are in the
same linkage group on chromosome 19. Individu¬
als who are secretors, homozygous (Se, Se) or
heterozygous (Se, se) for the secretor gene, will
have the type 1 form of their ABO blood group
antigens in their body fluids. Those of the 'reces¬
sive' non-secretor genotype (se, se) do not have
type 1 ABO antigens in their body fluids (Table
2).
Production of Lewis antigen is dependent on
fucosyl transferases coded for by the Se gene and
the Le genes. Both enzymes add fucose to type 1
precursor chains from which most of the ABO
and Lewis antigens in secretions derived. If the
Se transferase adds fucose to the terminal sugar
of the precursor chain, the Le enzyme can add
fucose to the subterminal sugar to produce
Lewis b. If the Le enzyme adds fucose to the
subterminal sugar first to produce Lewis a, the
secretor enzyme cannot use this structure as a
substrate, and Lewis a is the final product [28]. In
infants, the fucosyl transferase coded for by the
Se gene is less efficient than that coded for by the
Le gene; consequently, infants express easily de¬
tectable amounts of Lewis a even though the
amount might be greatly reduced as they become
older.
If Lewis a antigen is predominately expressed
on the cells of infants' during the first months of
life [29], this might contribute to their coloniza¬
tion by bacteria expressing adhesins that bind to
Lewis a. The incidence of SIDS closely parallels
the expression of the Lewis a antigen in infants
[30,31] and isolation of staphylococci from infants
[32]. Colonization by toxigenic staphylococcal
strains in such circumstances would not necessar¬
ily lead to SIDS. Other environmental factors,
e.g. virus infection, or overheating, are probably
needed to trigger the toxin production and the
series of events leading to cot deaths [31].
Studies with the anti-idiotypic reagent suggest
adhesins that bind Lewis a are present on a sig¬
nificant proportion of other species that affect
infants (Neisseria meningitidis and type b Haemo¬
philus influenzae) [19]. The method described here
is being adapted to isolate the Lewis a adhesin
from Gram-negative bacteria.
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